CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | alpha-CH2-containing aldehyde |
|
Accession: | CHEBI:73359
|
browse the term
|
Definition: | An aldehyde of general formula R-CH2-CH=O in which the aldehydic C=O function is attached to a CH2 group at the alpha-position. |
Synonyms: | related_synonym: | Formula=C2H3OR; SMILES=[*]CC=O; a 2,3-saturated aldehyde; alpha-CH2-containing aldehydes; alpha-methylene aldehyde; alpha-methylene aldehydes |
| alt_id: | CHEBI:77661 |
|
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
affects binding |
EXP |
3,4-dihydroxyphenylacetaldehyde binds to ALDH2 protein |
CTD |
PMID:21238438 |
|
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
affects binding |
EXP |
3,4-dihydroxyphenylacetaldehyde binds to GSTM1 protein |
CTD |
PMID:21238438 |
|
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Th |
tyrosine hydroxylase |
affects binding decreases activity multiple interactions |
EXP |
3,4-dihydroxyphenylacetaldehyde binds to TH protein 3,4-dihydroxyphenylacetaldehyde results in decreased activity of TH protein [3,4-dihydroxyphenylacetaldehyde results in decreased activity of TH protein] which results in decreased chemical synthesis of Levodopa |
CTD |
PMID:21238438 PMID:21514317 |
|
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
|
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
affects response to substance |
ISO |
BCL2 protein affects the susceptibility to methional |
CTD |
PMID:8611183 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
multiple interactions |
ISO |
methional inhibits the reaction [[CYP2D6 protein co-treated with Copper] results in increased activity of Eugenol] |
CTD |
PMID:15576237 |
|
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
|
G |
Akr1b10 |
aldo-keto reductase family 1 member B10 |
increases reduction |
ISO |
AKR1B10 protein results in increased reduction of isocaproaldehyde |
CTD |
PMID:19013440 |
|
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
|
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
increases expression |
ISO |
phenylacetaldehyde results in increased expression of AKR1C2 mRNA |
CTD |
PMID:20491607 |
|
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
|
|
G |
Tnf |
tumor necrosis factor |
increases secretion |
ISO |
phenylacetaldehyde results in increased secretion of TNF protein |
CTD |
PMID:17118622 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
|
G |
A1bg |
alpha-1-B glycoprotein |
increases expression |
ISO |
propionaldehyde results in increased expression of A1BG mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:92,493,934...92,498,460
Ensembl chr 7:92,494,372...92,498,097
|
|
G |
A2m |
alpha-2-macroglobulin |
increases expression |
ISO |
propionaldehyde results in increased expression of A2M mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
|
|
G |
Aanat |
aralkylamine N-acetyltransferase |
decreases expression |
ISO |
propionaldehyde results in decreased expression of AANAT mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:101,827,072...101,831,805
Ensembl chr10:101,827,301...101,831,801
|
|
G |
Aass |
aminoadipate-semialdehyde synthase |
increases expression |
ISO |
propionaldehyde results in increased expression of AASS mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:51,606,461...51,663,136
Ensembl chr 4:51,606,462...51,663,136
|
|
G |
Abat |
4-aminobutyrate aminotransferase |
increases expression |
ISO |
propionaldehyde results in increased expression of ABAT mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:6,996,688...7,092,835
Ensembl chr10:6,999,819...7,092,835
|
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ABCA1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
|
|
G |
Abca4 |
ATP binding cassette subfamily A member 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of ABCA4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:210,164,813...210,302,069
Ensembl chr 2:210,164,813...210,302,069
|
|
G |
Abcb5 |
ATP binding cassette subfamily B member 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of ABCB5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:139,836,528...139,932,830
Ensembl chr 6:139,835,949...139,932,830
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ABCC3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
|
|
G |
Abcc6 |
ATP binding cassette subfamily C member 6 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ABCC6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:96,447,224...96,501,464
Ensembl chr 1:96,447,251...96,501,464
|
|
G |
Abcg4 |
ATP binding cassette subfamily G member 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of ABCG4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:44,611,187...44,629,818
Ensembl chr 8:44,611,187...44,626,881
|
|
G |
Abcg5 |
ATP binding cassette subfamily G member 5 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ABCG5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563
|
|
G |
Abhd8 |
abhydrolase domain containing 8 |
increases expression |
ISO |
propionaldehyde results in increased expression of ABHD8 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:18,144,464...18,151,201
Ensembl chr16:18,144,464...18,157,667
|
|
G |
Ablim3 |
actin binding LIM protein family, member 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of ABLIM3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:55,256,135...55,376,629
Ensembl chr18:55,257,583...55,376,380
|
|
G |
Acmsd |
aminocarboxymuconate semialdehyde decarboxylase |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ACMSD mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:39,200,412...39,245,954
Ensembl chr13:39,200,314...39,245,209
|
|
G |
Acot4 |
acyl-CoA thioesterase 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of ACOT4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:103,668,699...103,674,037
Ensembl chr 6:103,668,753...103,673,917
|
|
G |
Acot9 |
acyl-CoA thioesterase 9 |
increases methylation |
ISO |
propionaldehyde results in increased methylation of ACOT9 gene |
CTD |
PMID:30002397 |
|
NCBI chr X:40,073,197...40,123,573
Ensembl chr X:40,064,810...40,123,559
|
|
G |
Acrv1 |
acrosomal vesicle protein 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ACRV1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:36,404,394...36,409,971
Ensembl chr 8:36,404,394...36,424,959
|
|
G |
Acta1 |
actin, alpha 1, skeletal muscle |
increases expression |
ISO |
propionaldehyde results in increased expression of ACTA1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:51,883,709...51,886,735
Ensembl chr19:51,883,715...51,886,742
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
increases expression |
ISO |
propionaldehyde results in increased expression of ACTA2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Acvrl1 |
activin A receptor like type 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ACVRL1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:132,239,200...132,256,592
Ensembl chr 7:132,239,729...132,256,591
|
|
G |
Adam11 |
ADAM metallopeptidase domain 11 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADAM11 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:87,724,115...87,742,773
Ensembl chr10:87,724,234...87,741,562
|
|
G |
Adam19 |
ADAM metallopeptidase domain 19 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADAM19 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:30,491,362...30,583,115
Ensembl chr10:30,491,405...30,583,105
|
|
G |
Adam21 |
ADAM metallopeptidase domain 21 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADAM21 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:36,625,324...36,627,657
Ensembl chr16:36,618,860...36,628,008
|
|
G |
Adam33 |
ADAM metallopeptidase domain 33 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ADAM33 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:118,262,395...118,283,456
Ensembl chr 3:118,271,029...118,283,461
|
|
G |
Adamts10 |
ADAM metallopeptidase with thrombospondin type 1 motif, 10 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ADAMTS10 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:14,331,659...14,361,620
Ensembl chr 7:14,331,745...14,361,620
|
|
G |
Adamts14 |
ADAM metallopeptidase with thrombospondin type 1 motif, 14 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADAMTS14 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr20:29,143,029...29,219,846
Ensembl chr20:29,144,354...29,219,866
|
|
G |
Adamts17 |
ADAM metallopeptidase with thrombospondin type 1 motif, 17 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ADAMTS17 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:120,445,800...120,768,204
Ensembl chr 1:120,445,749...120,768,202
|
|
G |
Adamts19 |
ADAM metallopeptidase with thrombospondin type 1 motif, 19 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ADAMTS19 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:52,346,448...52,531,245
Ensembl chr18:52,347,428...52,530,509
|
|
G |
Adamts4 |
ADAM metallopeptidase with thrombospondin type 1 motif, 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADAMTS4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:83,670,556...83,680,045
Ensembl chr13:83,670,183...83,680,065
|
|
G |
Adamts6 |
ADAM metallopeptidase with thrombospondin type 1 motif, 6 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADAMTS6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:35,421,483...35,633,305
Ensembl chr 2:35,421,510...35,633,298
|
|
G |
Adamtsl3 |
ADAMTS-like 3 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ADAMTSL3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:136,288,793...136,596,986
Ensembl chr 1:136,288,793...136,596,986
|
|
G |
Adamtsl4 |
ADAMTS-like 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADAMTSL4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:183,235,634...183,247,091
Ensembl chr 2:183,235,646...183,246,848
|
|
G |
Adap2 |
ArfGAP with dual PH domains 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADAP2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:65,138,006...65,166,147
Ensembl chr10:65,138,020...65,165,604
|
|
G |
Adgra2 |
adhesion G protein-coupled receptor A2 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADGRA2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:64,932,964...64,971,433
Ensembl chr16:64,933,315...64,971,483
|
|
G |
Adgrb1 |
adhesion G protein-coupled receptor B1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADGRB1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:106,404,827...106,476,902
Ensembl chr 7:106,404,958...106,476,902
|
|
G |
Adgre1 |
adhesion G protein-coupled receptor E1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADGRE1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:2,242,476...2,398,000
Ensembl chr 9:2,242,474...2,398,000
|
|
G |
Adgrf4 |
adhesion G protein-coupled receptor F4 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADGRF4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:18,272,050...18,303,219
Ensembl chr 9:18,272,050...18,303,217
|
|
G |
Adgrv1 |
adhesion G protein-coupled receptor V1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADGRV1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:11,331,434...11,911,713
Ensembl chr 2:11,331,442...11,911,688
|
|
G |
Adh1c |
alcohol dehydrogenase 1C (class I), gamma polypeptide |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ADH1C mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:226,797,303...226,808,892
Ensembl chr 2:226,797,303...226,808,892
|
|
G |
Adh6 |
alcohol dehydrogenase 6 (class V) |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ADH6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:226,903,208...226,934,564
Ensembl chr 2:226,903,250...226,934,534
|
|
G |
Adora2a |
adenosine A2a receptor |
increases expression |
ISO |
propionaldehyde results in increased expression of ADORA2A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr20:13,315,848...13,333,386
Ensembl chr20:13,315,853...13,333,386
|
|
G |
Adrb1 |
adrenoceptor beta 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADRB1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:255,771,962...255,774,973
Ensembl chr 1:255,771,597...255,807,259
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of ADRB2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
|
|
G |
Adtrp |
androgen-dependent TFPI-regulating protein |
increases expression |
ISO |
propionaldehyde results in increased expression of ADTRP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:22,907,758...22,993,834
Ensembl chr17:22,930,740...22,993,826
|
|
G |
Afap1l2 |
actin filament associated protein 1-like 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of AFAP1L2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:255,964,238...256,060,828
Ensembl chr 1:255,964,238...256,060,820
|
|
G |
Aff2 |
ALF transcription elongation factor 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of AFF2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:147,928,130...148,432,484
Ensembl chr X:147,928,407...148,429,995
|
|
G |
Agap2 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of AGAP2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:62,897,282...62,914,295
Ensembl chr 7:62,897,282...62,914,295
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
decreases expression |
ISO |
propionaldehyde results in decreased expression of AGER mRNA |
CTD |
PMID:26079696 |
|
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
|
|
G |
Agt |
angiotensinogen |
decreases expression |
ISO |
propionaldehyde results in decreased expression of AGT mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
decreases expression |
ISO |
propionaldehyde results in decreased expression of AGTR1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
|
|
G |
Ahnak2 |
AHNAK nucleoprotein 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of AHNAK2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:131,830,668...131,876,311
|
|
G |
Ahrr |
aryl-hydrocarbon receptor repressor |
increases expression |
ISO |
propionaldehyde results in increased expression of AHRR mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:28,993,634...29,088,673
Ensembl chr 1:28,993,634...29,088,673
|
|
G |
Aif1l |
allograft inflammatory factor 1-like |
increases expression |
ISO |
propionaldehyde results in increased expression of AIF1L mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:15,229,476...15,254,033
Ensembl chr 3:15,229,524...15,254,023
|
|
G |
Aire |
autoimmune regulator |
increases methylation |
ISO |
propionaldehyde results in increased methylation of AIRE gene |
CTD |
PMID:30002397 |
|
NCBI chr20:10,636,058...10,651,060
Ensembl chr20:10,636,123...10,651,060
|
|
G |
Akr1b1 |
aldo-keto reductase family 1 member B1 |
affects reduction increases reduction |
ISO |
AKR1B1 protein affects the reduction of propionaldehyde analog AKR1B1 protein results in increased reduction of propionaldehyde |
CTD |
PMID:9890881 PMID:11306073 |
|
NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
increases oxidation increases metabolic processing multiple interactions |
EXP ISO |
ALDH1A1 protein results in increased oxidation of propionaldehyde ALDH1A1 protein results in increased metabolism of propionaldehyde [ALDH1A1 protein binds to NAD] which results in increased oxidation of propionaldehyde; [ALDH1A1 protein co-treated with NAD] results in increased oxidation of propionaldehyde; [NAD co-treated with propionaldehyde] inhibits the reaction [Acrolein results in decreased activity of ALDH1A1 protein]; propionaldehyde inhibits the reaction [Acrolein results in decreased activity of ALDH1A1 protein] |
CTD |
PMID:10559215 PMID:10856427 PMID:10998257 PMID:21256123 PMID:21349255 PMID:22339434 PMID:25450233 More...
|
|
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
|
|
G |
Aldh1a3 |
aldehyde dehydrogenase 1 family, member A3 |
increases expression |
ISO |
propionaldehyde results in increased expression of ALDH1A3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:119,982,272...120,017,416
Ensembl chr 1:119,982,277...120,017,436
|
|
G |
Aldh1b1 |
aldehyde dehydrogenase 1 family, member B1 |
multiple interactions |
ISO |
[ALDH1B1 protein co-treated with NAD] results in increased metabolism of propionaldehyde |
CTD |
PMID:7779080 |
|
NCBI chr 5:60,063,370...60,068,378
Ensembl chr 5:60,063,225...60,068,378
|
|
G |
Aldh1l1 |
aldehyde dehydrogenase 1 family, member L1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ALDH1L1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:123,059,989...123,106,471
Ensembl chr 4:123,060,008...123,106,465
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
affects metabolic processing increases oxidation increases metabolic processing multiple interactions |
ISO |
ALDH2 protein polymorphism affects the metabolism of propionaldehyde ALDH2 protein results in increased oxidation of propionaldehyde ALDH2 protein results in increased metabolism of propionaldehyde daidzin inhibits the reaction [ALDH2 protein results in increased oxidation of propionaldehyde]; Magnesium promotes the reaction [ALDH2 protein results in increased oxidation of propionaldehyde]; molinate inhibits the reaction [ALDH2 protein results in increased metabolism of propionaldehyde]; molinate metabolite inhibits the reaction [ALDH2 protein results in increased metabolism of propionaldehyde]; molinate sulfoxide inhibits the reaction [ALDH2 protein results in increased metabolism of propionaldehyde] |
CTD |
PMID:11744614 PMID:20954713 PMID:21349255 PMID:23295226 |
|
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
|
|
G |
Aldh3a1 |
aldehyde dehydrogenase 3 family, member A1 |
increases metabolic processing |
ISO |
ALDH3A1 protein results in increased metabolism of propionaldehyde |
CTD |
PMID:19822198 PMID:21256123 |
|
NCBI chr10:45,892,993...45,902,680
Ensembl chr10:45,892,924...45,902,681
|
|
G |
Aldh3b1 |
aldehyde dehydrogenase 3 family, member B1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ALDH3B1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:201,145,309...201,162,675
Ensembl chr 1:201,145,309...201,163,921
|
|
G |
Aldh4a1 |
aldehyde dehydrogenase 4 family, member A1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ALDH4A1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:151,880,002...151,905,491
Ensembl chr 5:151,830,701...151,925,345
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
increases expression |
ISO |
propionaldehyde results in increased expression of ALOX5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
|
|
G |
Alox5ap |
arachidonate 5-lipoxygenase activating protein |
increases expression |
ISO |
propionaldehyde results in increased expression of ALOX5AP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:5,748,941...5,772,986
Ensembl chr12:5,748,944...5,772,986
|
|
G |
Ambp |
alpha-1-microglobulin/bikunin precursor |
decreases expression |
ISO |
propionaldehyde results in decreased expression of AMBP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:76,568,094...76,578,416
Ensembl chr 5:76,568,094...76,578,331
|
|
G |
Amhr2 |
anti-Mullerian hormone receptor type 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of AMHR2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:133,579,152...133,588,874
Ensembl chr 7:133,579,393...133,588,258
|
|
G |
Amotl1 |
angiomotin-like 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of AMOTL1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:11,348,651...11,467,564
Ensembl chr 8:11,353,674...11,467,573
|
|
G |
Ampd3 |
adenosine monophosphate deaminase 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of AMPD3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:164,884,823...164,929,899
Ensembl chr 1:164,885,320...164,929,887
|
|
G |
Amph |
amphiphysin |
decreases expression |
ISO |
propionaldehyde results in decreased expression of AMPH mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:45,739,385...45,982,905
Ensembl chr17:45,739,395...45,983,315
|
|
G |
Angpt1 |
angiopoietin 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ANGPT1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:73,528,345...73,783,953
Ensembl chr 7:73,531,486...73,784,067
|
|
G |
Ankdd1a |
ankyrin repeat and death domain containing 1A |
increases expression |
ISO |
propionaldehyde results in increased expression of ANKDD1A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:66,017,571...66,043,738
Ensembl chr 8:66,017,773...66,042,651
|
|
G |
Ankh |
ANKH inorganic pyrophosphate transport regulator |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ANKH mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:78,153,027...78,280,181
Ensembl chr 2:78,153,026...78,280,187
|
|
G |
Ankrd1 |
ankyrin repeat domain 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ANKRD1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:233,815,851...233,834,891
Ensembl chr 1:233,815,851...233,834,919
|
|
G |
Ankrd2 |
ankyrin repeat domain 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of ANKRD2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:240,847,111...240,856,563
Ensembl chr 1:240,847,072...240,856,566
|
|
G |
Ankrd29 |
ankyrin repeat domain 29 |
increases expression |
ISO |
propionaldehyde results in increased expression of ANKRD29 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:3,436,301...3,494,292
Ensembl chr18:3,436,303...3,494,296
|
|
G |
Ankrd34a |
ankyrin repeat domain 34A |
increases expression |
ISO |
propionaldehyde results in increased expression of ANKRD34A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:184,129,830...184,135,075
Ensembl chr 2:184,129,238...184,135,116
|
|
G |
Ankrd34b |
ankyrin repeat domain 34B |
increases expression |
ISO |
propionaldehyde results in increased expression of ANKRD34B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:23,651,083...23,668,041
Ensembl chr 2:23,651,474...23,668,030
|
|
G |
Ankrd55 |
ankyrin repeat domain 55 |
increases expression |
ISO |
propionaldehyde results in increased expression of ANKRD55 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:43,883,877...43,983,820
Ensembl chr 2:43,883,857...43,983,680
|
|
G |
Anks4b |
ankyrin repeat and sterile alpha motif domain containing 4B |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ANKS4B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:174,534,195...174,557,798
Ensembl chr 1:174,547,473...174,557,797
|
|
G |
Anln |
anillin, actin binding protein |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ANLN mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:20,858,227...20,921,602
Ensembl chr 8:20,858,228...20,921,538
|
|
G |
Anp32b |
acidic nuclear phosphoprotein 32 family member B |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ANP32B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:60,743,077...60,765,726
Ensembl chr 5:60,743,443...60,765,717
|
|
G |
Anp32e |
acidic nuclear phosphoprotein 32 family member E |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ANP32E mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:183,472,600...183,489,057
Ensembl chr 2:183,472,609...183,489,054
|
|
G |
Antxr1 |
ANTXR cell adhesion molecule 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ANTXR1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:119,590,770...119,778,232
Ensembl chr 4:119,590,771...119,778,232
|
|
G |
Antxr2 |
ANTXR cell adhesion molecule 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of ANTXR2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:11,541,718...11,682,110
Ensembl chr14:11,541,772...11,682,094
|
|
G |
Anxa10 |
annexin A10 |
increases expression |
ISO |
propionaldehyde results in increased expression of ANXA10 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:27,738,712...27,805,648
Ensembl chr16:27,738,712...27,805,648
|
|
G |
Anxa11 |
annexin A11 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ANXA11 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:1,412,373...1,457,814
Ensembl chr16:1,410,756...1,457,797
|
|
G |
Anxa13 |
annexin A13 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ANXA13 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:89,884,356...89,936,907
Ensembl chr 7:89,884,356...89,936,907
|
|
G |
Anxa6 |
annexin A6 |
increases expression |
ISO |
propionaldehyde results in increased expression of ANXA6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:39,101,395...39,156,483
Ensembl chr10:39,097,109...39,156,433
|
|
G |
Aoc3 |
amine oxidase, copper containing 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of AOC3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:86,272,757...86,280,702
|
|
G |
Aox1 |
aldehyde oxidase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of AOX1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:59,579,621...59,658,772
Ensembl chr 9:59,579,649...59,658,770
|
|
G |
Ap1m2 |
adaptor related protein complex 1 subunit mu 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of AP1M2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:19,838,579...19,856,560
Ensembl chr 8:19,838,580...19,856,482
|
|
G |
Ap1s1 |
adaptor related protein complex 1 subunit sigma 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of AP1S1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:19,625,267...19,635,792
Ensembl chr12:19,625,332...19,756,713
|
|
G |
Ap1s3 |
adaptor related protein complex 1 subunit sigma 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of AP1S3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:80,950,402...81,009,889
Ensembl chr 9:80,950,715...81,009,798
|
|
G |
Apoa1 |
apolipoprotein A1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of APOA1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
|
|
G |
Apobec3 |
apolipoprotein B mRNA editing enzyme catalytic subunit 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of APOBEC3H mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:111,433,789...111,453,032
Ensembl chr 7:111,433,764...111,452,922
|
|
G |
Apod |
apolipoprotein D |
increases expression |
ISO |
propionaldehyde results in increased expression of APOD mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:69,431,261...69,452,306
Ensembl chr11:69,431,260...69,452,305
|
|
G |
Apoe |
apolipoprotein E |
increases expression |
ISO |
propionaldehyde results in increased expression of APOE mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
|
|
G |
Apoh |
apolipoprotein H |
decreases expression |
ISO |
propionaldehyde results in decreased expression of APOH mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:93,342,435...93,356,334
Ensembl chr10:93,310,977...93,356,329
|
|
G |
Apol9a |
apolipoprotein L9a |
decreases expression |
ISO |
propionaldehyde results in decreased expression of APOL4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:109,140,871...109,149,799
Ensembl chr 7:109,140,871...109,147,649
|
|
G |
Apold1 |
apolipoprotein L domain containing 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of APOLD1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:167,768,437...167,825,706
Ensembl chr 4:167,818,271...167,825,706
|
|
G |
Aqp3 |
aquaporin 3 (Gill blood group) |
decreases expression |
ISO |
propionaldehyde results in decreased expression of AQP3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:56,239,200...56,244,718
Ensembl chr 5:56,239,201...56,244,720
|
|
G |
Arc |
activity-regulated cytoskeleton-associated protein |
increases expression |
ISO |
propionaldehyde results in increased expression of ARC mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:106,555,968...106,559,697
Ensembl chr 7:106,555,785...106,559,378
|
|
G |
Areg |
amphiregulin |
increases expression |
ISO |
propionaldehyde results in increased expression of AREG mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535
|
|
G |
Arg2 |
arginase 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of ARG2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378
|
|
G |
Arhgap11a |
Rho GTPase activating protein 11A |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ARHGAP11A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:100,590,865...100,607,146
Ensembl chr 3:100,590,865...100,607,559
|
|
G |
Arhgap22 |
Rho GTPase activating protein 22 |
increases expression |
ISO |
propionaldehyde results in increased expression of ARHGAP22 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:8,473,806...8,631,552
Ensembl chr16:8,476,306...8,631,548
|
|
G |
Arhgap25 |
Rho GTPase activating protein 25 |
increases expression |
ISO |
propionaldehyde results in increased expression of ARHGAP25 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:119,896,844...119,974,982
Ensembl chr 4:119,896,844...119,974,982
|
|
G |
Arhgdib |
Rho GDP dissociation inhibitor beta |
increases expression |
ISO |
propionaldehyde results in increased expression of ARHGDIB mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:169,822,951...169,841,884
Ensembl chr 4:169,822,952...169,841,658
|
|
G |
Arhgef4 |
Rho guanine nucleotide exchange factor 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of ARHGEF4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:36,861,800...37,005,079
Ensembl chr 9:36,861,835...37,005,075
|
|
G |
Arl14 |
ADP-ribosylation factor like GTPase 14 |
increases expression |
ISO |
propionaldehyde results in increased expression of ARL14 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:153,468,863...153,470,102
Ensembl chr 2:153,468,977...153,469,555
|
|
G |
Arl4c |
ADP ribosylation factor like GTPase 4C |
increases expression |
ISO |
propionaldehyde results in increased expression of ARL4C mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:89,300,335...89,303,770
Ensembl chr 9:89,298,005...89,304,513
|
|
G |
Armc3 |
armadillo repeat containing 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of ARMC3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:81,814,087...81,917,534
Ensembl chr17:81,832,518...81,917,531
|
|
G |
Armh1 |
armadillo-like helical domain containing 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ARMH1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:130,680,955...130,722,062
Ensembl chr 5:130,682,485...130,722,062
|
|
G |
Armh4 |
armadillo-like helical domain containing 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of ARMH4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:22,975,895...23,076,986
Ensembl chr15:22,975,895...23,076,949
|
|
G |
Arrb1 |
arrestin, beta 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ARRB1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:153,837,964...153,912,111
Ensembl chr 1:153,838,078...153,904,061
|
|
G |
Arsg |
arylsulfatase G |
increases expression |
ISO |
propionaldehyde results in increased expression of ARSG mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:94,412,261...94,551,224
Ensembl chr10:94,447,399...94,542,941
|
|
G |
Arsi |
arylsulfatase family, member I |
increases expression |
ISO |
propionaldehyde results in increased expression of ARSI mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:54,364,160...54,371,772
Ensembl chr18:54,364,088...54,371,767
|
|
G |
Art4 |
ADP-ribosyltransferase 4 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ART4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:169,740,331...169,751,571
Ensembl chr 4:169,740,331...169,750,665
|
|
G |
Arvcf |
ARVCF, delta catenin family member |
increases expression |
ISO |
propionaldehyde results in increased expression of ARVCF mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:82,588,137...82,645,832
Ensembl chr11:82,587,881...82,645,805
|
|
G |
Arx |
aristaless related homeobox |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ARX mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:58,016,233...58,028,149
Ensembl chr X:58,016,233...58,028,142
|
|
G |
Asb18 |
ankyrin repeat and SOCS box-containing 18 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ASB18 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:90,531,350...90,595,953
Ensembl chr 9:90,531,596...90,595,848
|
|
G |
Asb2 |
ankyrin repeat and SOCS box-containing 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of ASB2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:122,474,754...122,511,014
Ensembl chr 6:122,474,756...122,510,854
|
|
G |
Asb4 |
ankyrin repeat and SOCS box-containing 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of ASB4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:33,506,992...33,544,630
Ensembl chr 4:33,506,992...33,544,630
|
|
G |
Asf1b |
anti-silencing function 1B histone chaperone |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ASF1B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:24,181,024...24,195,604
Ensembl chr19:24,181,028...24,195,549
|
|
G |
Asgr1 |
asialoglycoprotein receptor 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ASGR1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:54,775,727...54,779,642
Ensembl chr10:54,776,024...54,779,631
|
|
G |
Asgr2 |
asialoglycoprotein receptor 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ASGR2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:54,821,407...54,834,624
Ensembl chr10:54,821,438...54,834,617
|
|
G |
Asmt |
acetylserotonin O-methyltransferase |
increases expression |
ISO |
propionaldehyde results in increased expression of ASMT mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:16,304,719...16,309,568
Ensembl chr12:16,304,719...16,309,568
|
|
G |
Asmtl |
acetylserotonin O-methyltransferase-like |
increases expression |
ISO |
propionaldehyde results in increased expression of ASMTL mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:16,315,335...16,318,083
Ensembl chr12:16,315,414...16,318,080
|
|
G |
Asphd2 |
aspartate beta-hydroxylase domain containing 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of ASPHD2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:44,248,132...44,258,653
Ensembl chr12:44,248,145...44,257,772
|
|
G |
Aspm |
assembly factor for spindle microtubules |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ASPM mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:51,074,849...51,123,755
Ensembl chr13:51,074,849...51,123,755
|
|
G |
Ass1 |
argininosuccinate synthase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ASS1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903
|
|
G |
Astn2 |
astrotactin 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of ASTN2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:78,758,142...79,744,021
Ensembl chr 5:78,758,142...79,748,273
|
|
G |
Atcay |
ATCAY kinesin light chain interacting caytaxin |
increases expression |
ISO |
propionaldehyde results in increased expression of ATCAY mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:8,487,763...8,511,527
Ensembl chr 7:8,487,763...8,512,663
|
|
G |
Atp1a2 |
ATPase Na+/K+ transporting subunit alpha 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of ATP1A2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:84,729,597...84,754,544
Ensembl chr13:84,729,601...84,754,544
|
|
G |
Atp1b2 |
ATPase Na+/K+ transporting subunit beta 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of ATP1B2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:54,318,698...54,324,933
Ensembl chr10:54,318,701...54,324,933
|
|
G |
Atp2a3 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of ATP2A3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:57,581,742...57,612,758
Ensembl chr10:57,582,128...57,612,748
|
|
G |
Atp4a |
ATPase H+/K+ transporting subunit alpha |
increases expression |
ISO |
propionaldehyde results in increased expression of ATP4A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:85,961,607...85,974,972
Ensembl chr 1:85,961,708...85,974,844
|
|
G |
Atp6v0a4 |
ATPase H+ transporting V0 subunit a4 |
increases expression |
ISO |
propionaldehyde results in increased expression of ATP6V0A4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:66,760,163...66,842,126
Ensembl chr 4:66,760,159...66,842,110
|
|
G |
Atp8b3 |
ATPase phospholipid transporting 8B3 |
increases expression |
ISO |
propionaldehyde results in increased expression of ATP8B3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:9,175,544...9,195,449
Ensembl chr 7:9,175,391...9,195,442
|
|
G |
Aurkb |
aurora kinase B |
decreases expression |
ISO |
propionaldehyde results in decreased expression of AURKB mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837
|
|
G |
B3galt4 |
Beta-1,3-galactosyltransferase 4 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of B3GALT4 mRNA |
CTD |
PMID:25014914 PMID:26079696 |
|
NCBI chr20:4,936,089...4,937,664
Ensembl chr20:4,931,768...4,938,315
|
|
G |
B3gnt6 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of B3GNT6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:152,484,572...152,496,226
Ensembl chr 1:152,486,343...152,492,150
|
|
G |
Baat |
bile acid CoA:amino acid N-acyltransferase |
decreases expression |
ISO |
propionaldehyde results in decreased expression of BAAT mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:63,851,668...63,860,641
Ensembl chr 5:63,850,705...63,860,685
|
|
G |
Baiap3 |
BAI1-associated protein 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of BAIAP3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:14,260,269...14,273,019
Ensembl chr10:14,260,269...14,273,019
|
|
G |
Bard1 |
BRCA1 associated RING domain 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of BARD1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:72,616,070...72,694,553
Ensembl chr 9:72,623,155...72,694,265
|
|
G |
Barx1 |
BARX homeobox 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of BARX1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:15,990,412...15,993,887
Ensembl chr17:15,990,412...15,993,887
|
|
G |
Batf2 |
basic leucine zipper ATF-like transcription factor 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of BATF2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:203,467,291...203,479,428
Ensembl chr 1:203,468,097...203,475,889
|
|
G |
Batf3 |
basic leucine zipper ATF-like transcription factor 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of BATF3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:102,689,657...102,701,241
Ensembl chr13:102,689,657...102,701,139
|
|
G |
Bcl11a |
BCL11 transcription factor A |
increases expression |
ISO |
propionaldehyde results in increased expression of BCL11A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:98,029,018...98,124,181
Ensembl chr14:98,030,461...98,124,180
|
|
G |
Bcl2a1 |
BCL2-related protein A1 |
increases expression |
ISO |
propionaldehyde results in increased expression of BCL2A1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:89,716,914...89,724,998
Ensembl chr 8:89,716,914...89,724,998
|
|
G |
Bcl2l10 |
Bcl2-like 10 |
increases expression |
ISO |
propionaldehyde results in increased expression of BCL2L10 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:76,107,326...76,113,373
Ensembl chr 8:76,107,326...76,113,367
|
|
G |
Bco2 |
beta-carotene oxygenase 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of BCO2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:50,882,174...50,907,676
Ensembl chr 8:50,882,181...50,915,467
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
increases expression |
ISO |
propionaldehyde results in increased expression of BDNF mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Bex1 |
brain expressed X-linked 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of BEX2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:99,219,014...99,220,518
Ensembl chr X:99,219,014...99,220,958
|
|
G |
Bex4 |
brain expressed, X-linked 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of BEX4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:99,131,985...99,133,417
Ensembl chr X:99,131,942...99,133,531
|
|
G |
Bhlhe41 |
basic helix-loop-helix family, member e41 |
increases expression |
ISO |
propionaldehyde results in increased expression of BHLHE41 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:178,834,264...178,838,618
Ensembl chr 4:178,834,271...178,838,468
|
|
G |
Bicra |
BRD4 interacting chromatin remodeling complex associated protein |
decreases expression |
ISO |
propionaldehyde results in decreased expression of BICRA mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:76,661,897...76,736,146
Ensembl chr 1:76,661,897...76,737,157
|
|
G |
Bik |
BCL2-interacting killer |
increases expression |
ISO |
propionaldehyde results in increased expression of BIK mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:114,672,277...114,691,296
Ensembl chr 7:114,672,277...114,691,296
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of BIRC3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of BIRC5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Blm |
BLM RecQ like helicase |
decreases expression |
ISO |
propionaldehyde results in decreased expression of BLM mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:134,409,832...134,496,073
Ensembl chr 1:134,409,857...134,484,312
|
|
G |
Bmp10 |
bone morphogenetic protein 10 |
increases methylation |
ISO |
propionaldehyde results in increased methylation of BMP10 gene |
CTD |
PMID:30002397 |
|
NCBI chr 4:119,872,066...119,877,694
Ensembl chr 4:119,872,045...119,878,627
|
|
G |
Bmp6 |
bone morphogenetic protein 6 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of BMP6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:26,318,121...26,469,691
Ensembl chr17:26,318,569...26,470,365
|
|
G |
Bmp7 |
bone morphogenetic protein 7 |
increases expression |
ISO |
propionaldehyde results in increased expression of BMP7 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:161,639,915...161,716,938
Ensembl chr 3:161,516,462...161,716,788
|
|
G |
Bmp8a |
bone morphogenetic protein 8a |
increases expression |
ISO |
propionaldehyde results in increased expression of BMP8A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:135,589,839...135,617,785
Ensembl chr 5:135,591,716...135,617,785
|
|
G |
Bmper |
BMP-binding endothelial regulator |
increases expression |
ISO |
propionaldehyde results in increased expression of BMPER mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:21,732,225...21,977,261
Ensembl chr 8:21,732,225...21,977,256
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
decreases expression |
ISO |
propionaldehyde results in decreased expression of BRCA1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
|
|
G |
Brip1 |
BRCA1 interacting helicase 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of BRIP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:70,907,266...71,031,502
Ensembl chr10:70,907,371...71,030,324
|
|
G |
Brpf3 |
bromodomain and PHD finger containing, 3 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of BRPF3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr20:6,864,684...6,902,760
Ensembl chr20:6,865,985...6,902,690
|
|
G |
Btbd17 |
BTB domain containing 17 |
increases expression |
ISO |
propionaldehyde results in increased expression of BTBD17 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:99,826,132...99,832,624
Ensembl chr10:99,826,132...99,832,624
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of BTG2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
|
|
G |
Bub1 |
BUB1 mitotic checkpoint serine/threonine kinase |
decreases expression |
ISO |
propionaldehyde results in decreased expression of BUB1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:115,020,254...115,051,650
Ensembl chr 3:115,020,254...115,051,650
|
|
G |
Bub1b |
BUB1 mitotic checkpoint serine/threonine kinase B |
decreases expression |
ISO |
propionaldehyde results in decreased expression of BUB1B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:105,563,089...105,615,547
Ensembl chr 3:105,563,138...105,615,547
|
|
G |
C10h16orf96 |
similar to human chromosome 16 open reading frame 96 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of C16ORF96 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:10,707,529...10,750,893
|
|
G |
C13h1orf116 |
similar to human chromosome 1 open reading frame 116 |
increases expression |
ISO |
propionaldehyde results in increased expression of C1ORF116 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:42,187,442...42,201,432
Ensembl chr13:42,188,609...42,201,426
|
|
G |
C13h1orf226 |
similar to human chromosome 1 open reading frame 226 |
increases expression |
ISO |
propionaldehyde results in increased expression of C1ORF226 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:82,530,589...82,538,676
Ensembl chr13:82,530,577...82,820,949
|
|
G |
C17h10orf67 |
similar to human chromosome 10 open reading frame 67 |
increases expression |
ISO |
propionaldehyde results in increased expression of C10ORF67 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:82,062,461...82,174,401
Ensembl chr17:82,071,838...82,174,353
|
|
G |
C19h16orf86 |
similar to human chromosome 16 open reading frame 86 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of C16ORF86 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:33,596,591...33,598,703
Ensembl chr19:33,595,995...33,598,521
|
|
G |
C1h10orf90 |
similar to human chromosome 10 open reading frame 90 |
increases expression |
ISO |
propionaldehyde results in increased expression of C10ORF90 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:189,059,744...189,293,353
Ensembl chr 1:189,059,746...189,293,435
|
|
G |
C1h19orf18 |
similar to human chromosome 19 open reading frame 18 |
increases expression |
ISO |
propionaldehyde results in increased expression of C19ORF18 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:73,022,324...73,049,934
Ensembl chr 1:73,025,988...73,049,736
|
|
G |
C1h9orf57 |
similar to human chromosome 9 open reading frame 57 |
decreases methylation |
ISO |
propionaldehyde results in decreased methylation of C9ORF57 gene |
CTD |
PMID:30002397 |
|
NCBI chr 1:219,079,683...219,084,806
Ensembl chr 1:219,079,683...219,084,806
|
|
G |
C1qb |
complement C1q B chain |
decreases expression |
ISO |
propionaldehyde results in decreased expression of C1QB mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:149,118,843...149,124,394
Ensembl chr 5:149,118,846...149,124,407
|
|
G |
C1ql4 |
complement C1q like 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of C1QL4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:130,243,606...130,246,678
Ensembl chr 7:130,243,606...130,246,678
|
|
G |
C1qtnf5 |
C1q and TNF related 5 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of C1QTNF5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:44,450,934...44,453,075
Ensembl chr 8:44,451,154...44,453,074
|
|
G |
C1qtnf6 |
C1q and TNF related 6 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of C1QTNF6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:110,077,867...110,084,584
Ensembl chr 7:110,077,878...110,084,412
|
|
G |
C1r |
complement C1r |
decreases expression |
ISO |
propionaldehyde results in decreased expression of C1R mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:157,412,718...157,423,483
Ensembl chr 4:157,412,692...157,423,484
|
|
G |
C1s |
complement C1s |
decreases expression |
ISO |
propionaldehyde results in decreased expression of C1S mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:157,430,249...157,442,438
Ensembl chr 4:157,430,117...157,442,303
|
|
G |
C2 |
complement C2 |
increases expression |
ISO |
propionaldehyde results in increased expression of C2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr20:3,951,474...3,970,376
Ensembl chr20:3,951,474...3,976,505
|
|
G |
C2h1orf54 |
similar to human chromosome 1 open reading frame 54 |
increases expression |
ISO |
propionaldehyde results in increased expression of C1ORF54 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:183,424,989...183,434,713
Ensembl chr 2:183,424,984...183,435,089
|
|
G |
C3h11orf91 |
similar to human chromosome 11 open reading frame 91 |
increases expression |
ISO |
propionaldehyde results in increased expression of C11ORF91 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:90,479,196...90,486,592
Ensembl chr 3:90,484,607...90,486,589
|
|
G |
C3h11orf96 |
similar to human chromosome 11 open reading frame 96 |
increases expression |
ISO |
propionaldehyde results in increased expression of C11ORF96 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:79,920,125...79,921,368
Ensembl chr 3:79,920,129...79,921,523
|
|
G |
C3h15orf48 |
similar to human chromosome 15 open reading frame 48 |
increases expression |
ISO |
propionaldehyde results in increased expression of C15ORF48 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:109,719,952...109,723,505
Ensembl chr 3:109,719,897...109,724,006 Ensembl chr 3:109,719,897...109,724,006
|
|
G |
C4bpa |
complement component 4 binding protein, alpha |
decreases expression |
ISO |
propionaldehyde results in decreased expression of C4BPA mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:42,075,715...42,111,205
Ensembl chr13:42,075,717...42,111,205
|
|
G |
C5h1orf127 |
similar to human chromosome 1 open reading frame 127 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of C1ORF127 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:159,075,217...159,110,642
Ensembl chr 5:159,075,343...159,105,369
|
|
G |
C5h8orf89 |
similar to human chromosome 8 open reading frame 89 |
increases expression |
ISO |
propionaldehyde results in increased expression of C8ORF89 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:3,225,586...3,247,575
Ensembl chr 5:3,225,638...3,247,589
|
|
G |
C5h9orf152 |
similar to human chromosome 9 open reading frame 152 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of C9ORF152 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:72,660,573...72,667,941
Ensembl chr 5:72,660,573...72,668,379
|
|
G |
C5h9orf43 |
similar to human chromosome 9 open reading frame 43 |
increases expression |
ISO |
propionaldehyde results in increased expression of C9ORF43 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:75,977,296...76,002,179
Ensembl chr 5:75,971,381...76,002,176
|
|
G |
C6 |
complement C6 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of C6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:53,846,028...53,921,279
Ensembl chr 2:53,851,985...53,921,275
|
|
G |
C8h11orf87 |
similar to human chromosome 11 open reading frame 87 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of C11ORF87 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:53,062,361...53,069,882
Ensembl chr 8:53,062,360...53,069,538
|
|
G |
C8h11orf97 |
similar to human chromosome 11 open reading frame 97 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of C11ORF97 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:11,603,225...11,618,729
Ensembl chr 8:11,603,225...11,618,729
|
|
G |
C9h6orf141 |
similar to human chromosome 6 open reading frame 141 |
increases expression |
ISO |
propionaldehyde results in increased expression of C6ORF141 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:20,024,916...20,029,094
Ensembl chr 9:20,024,916...20,029,094
|
|
G |
Cabp1 |
calcium binding protein 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CABP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:41,385,234...41,448,930
Ensembl chr12:41,378,897...41,448,927
|
|
G |
Cacna1b |
calcium voltage-gated channel subunit alpha1 B |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CACNA1B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:7,380,892...7,546,104
Ensembl chr 3:7,380,922...7,546,091
|
|
G |
Cacna1g |
calcium voltage-gated channel subunit alpha1 G |
increases expression |
ISO |
propionaldehyde results in increased expression of CACNA1G mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:79,354,998...79,422,960
Ensembl chr10:79,355,008...79,422,752
|
|
G |
Cacna1i |
calcium voltage-gated channel subunit alpha1 I |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CACNA1I mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:111,835,996...111,947,418
Ensembl chr 7:111,836,012...111,944,688
|
|
G |
Cacna2d2 |
calcium voltage-gated channel auxiliary subunit alpha2delta 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CACNA2D2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:108,072,208...108,203,516
Ensembl chr 8:108,072,454...108,203,173
|
|
G |
Cacng4 |
calcium voltage-gated channel auxiliary subunit gamma 4 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CACNG4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:92,683,778...92,745,842
Ensembl chr10:92,683,761...92,746,126
|
|
G |
Cacng7 |
calcium voltage-gated channel auxiliary subunit gamma 7 |
increases expression |
ISO |
propionaldehyde results in increased expression of CACNG7 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:65,800,059...65,831,246
Ensembl chr 1:65,800,355...65,831,006
|
|
G |
Cadm2 |
cell adhesion molecule 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CADM2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:4,548,367...5,525,420
Ensembl chr11:4,555,159...5,525,400
|
|
G |
Calca |
calcitonin-related polypeptide alpha |
increases expression |
ISO |
propionaldehyde results in increased expression of CALCA mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
|
|
G |
Calhm3 |
calcium homeostasis modulator 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of CALHM3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:246,043,258...246,048,259
Ensembl chr 1:246,043,258...246,048,259
|
|
G |
Camk2n1 |
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CAMK2N1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:150,674,819...150,676,600
Ensembl chr 5:150,673,507...150,676,600
|
|
G |
Camkv |
CaM kinase-like vesicle-associated |
increases expression |
ISO |
propionaldehyde results in increased expression of CAMKV mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:108,626,821...108,641,169
Ensembl chr 8:108,626,821...108,641,169
|
|
G |
Camp |
cathelicidin antimicrobial peptide |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CAMP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:109,841,729...109,843,543
Ensembl chr 8:109,841,729...109,843,543
|
|
G |
Camta1 |
calmodulin binding transcription activator 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CAMTA1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:161,510,283...162,356,902
Ensembl chr 5:161,510,283...162,356,723
|
|
G |
Capg |
capping actin protein, gelsolin like |
increases expression |
ISO |
propionaldehyde results in increased expression of CAPG mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:104,594,743...104,611,856
Ensembl chr 4:104,594,753...104,611,856
|
|
G |
Capn12 |
calpain 12 |
increases expression |
ISO |
propionaldehyde results in increased expression of CAPN12 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:84,171,059...84,183,161
Ensembl chr 1:84,171,059...84,183,119
|
|
G |
Capn3 |
calpain 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of CAPN3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:107,407,518...107,457,858
Ensembl chr 3:107,407,850...107,457,858
|
|
G |
Car4 |
carbonic anhydrase 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of CA4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:69,827,945...69,836,501
Ensembl chr10:69,827,945...69,836,501
|
|
G |
Car9 |
carbonic anhydrase 9 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CA9 mRNA |
CTD |
PMID:25014914 PMID:26079696 |
|
NCBI chr 5:57,763,234...57,769,838
Ensembl chr 5:57,763,206...57,769,838
|
|
G |
Card9 |
caspase recruitment domain family, member 9 |
increases expression |
ISO |
propionaldehyde results in increased expression of CARD9 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:9,171,814...9,180,310
Ensembl chr 3:9,171,815...9,180,237
|
|
G |
Carmn |
cardiac mesoderm enhancer-associated non-coding RNA |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CARMN mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:55,097,848...55,118,769
Ensembl chr18:55,095,230...55,118,825
|
|
G |
Carns1 |
carnosine synthase 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CARNS1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:201,459,061...201,470,019
Ensembl chr 1:201,459,076...201,469,845
|
|
G |
Catsperz |
catsper channel auxiliary subunit zeta |
increases expression |
ISO |
propionaldehyde results in increased expression of CATSPERZ mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:204,114,816...204,118,582
|
|
G |
Cc2d2b |
coiled-coil and C2 domain containing 2B |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CC2D2B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:239,561,506...239,655,771
Ensembl chr 1:239,561,987...239,682,416
|
|
G |
Ccbe1 |
collagen and calcium binding EGF domains 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCBE1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:59,579,851...59,823,977
Ensembl chr18:59,580,768...59,824,400
|
|
G |
Ccdc103 |
coiled-coil domain containing 103 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCDC103 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:87,846,327...87,849,959
Ensembl chr10:87,846,357...87,849,757
|
|
G |
Ccdc113 |
coiled-coil domain containing 113 |
increases expression |
ISO |
propionaldehyde results in increased expression of CFAP263 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:9,497,000...9,516,917
Ensembl chr19:9,496,886...9,516,923
|
|
G |
Ccdc121 |
coiled-coil domain containing 121 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CCDC121 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:24,970,845...24,973,451
Ensembl chr 6:24,970,833...24,973,478
|
|
G |
Ccdc146 |
coiled-coil domain containing 146 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCDC146 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:13,662,766...13,811,619
Ensembl chr 4:13,662,766...13,811,608
|
|
G |
Ccdc148 |
coiled-coil domain containing 148 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCDC148 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:43,356,885...43,631,999
Ensembl chr 3:43,356,892...43,631,991
|
|
G |
Ccdc15 |
coiled-coil domain containing 15 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CCDC15 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:36,991,147...37,068,849
Ensembl chr 8:36,998,867...37,068,919
|
|
G |
Ccdc160 |
coiled-coil domain containing 160 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCDC160 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:132,468,141...132,478,616
Ensembl chr X:132,468,213...132,478,431
|
|
G |
Ccdc169 |
coiled-coil domain containing 169 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCDC169 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:139,321,644...139,351,161
Ensembl chr 2:139,321,670...139,351,161
|
|
G |
Ccdc18 |
coiled-coil domain containing 18 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CCDC18 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:1,501,749...1,607,672
Ensembl chr14:1,501,784...1,607,711
|
|
G |
Ccdc28b |
coiled coil domain containing 28B |
increases expression |
ISO |
propionaldehyde results in increased expression of CCDC28B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:141,962,275...141,967,278
Ensembl chr 5:141,962,276...141,967,382
|
|
G |
Ccdc3 |
coiled-coil domain containing 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCDC3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:73,031,891...73,135,173
Ensembl chr17:73,035,045...73,135,337
|
|
G |
Ccdc30 |
coiled-coil domain containing 30 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCDC30 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:132,926,767...133,019,635
Ensembl chr 5:132,926,615...133,019,659
|
|
G |
Cck |
cholecystokinin |
increases expression |
ISO |
propionaldehyde results in increased expression of CCK mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:121,153,499...121,160,194
Ensembl chr 8:121,153,500...121,160,084
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCL2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCL20 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
|
|
G |
Ccl21 |
C-C motif chemokine ligand 21 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CCL21 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:56,980,557...56,981,661
Ensembl chr 5:56,980,558...56,981,686
|
|
G |
Ccl26 |
C-C motif chemokine ligand 26 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCL26 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:21,109,384...21,114,336
Ensembl chr12:21,109,421...21,114,335
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCL3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCL5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccl7 |
C-C motif chemokine ligand 7 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCL7 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
|
|
G |
Ccm2l |
CCM2 like scaffold protein |
increases expression |
ISO |
propionaldehyde results in increased expression of CCM2L mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:141,533,470...141,549,136
Ensembl chr 3:141,533,511...141,549,140
|
|
G |
Ccn3 |
cellular communication network factor 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCN3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:86,094,000...86,101,022
Ensembl chr 7:86,094,000...86,101,019
|
|
G |
Ccn5 |
cellular communication network factor 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCN5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:152,491,247...152,502,639
Ensembl chr 3:152,491,220...152,502,636
|
|
G |
Ccna1 |
cyclin A1 |
increases methylation |
ISO |
propionaldehyde results in increased methylation of CCNA1 gene |
CTD |
PMID:30002397 |
|
NCBI chr 2:139,231,738...139,278,066
Ensembl chr 2:139,201,074...139,243,157
|
|
G |
Ccna2 |
cyclin A2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CCNA2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnb1 |
cyclin B1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CCNB1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnb1ip1 |
cyclin B1 interacting protein 1 |
increases methylation |
ISO |
propionaldehyde results in increased methylation of CCNB1IP1 gene |
CTD |
PMID:30002397 |
|
NCBI chr15:24,014,905...24,031,357
Ensembl chr15:24,014,908...24,028,475
|
|
G |
Ccnb2 |
cyclin B2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CCNB2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
|
|
G |
Ccnd2 |
cyclin D2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CCND2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
|
|
G |
Ccne2 |
cyclin E2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CCNE2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:24,285,078...24,298,258
Ensembl chr 5:24,284,922...24,297,632
|
|
G |
Ccnf |
cyclin F |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CCNF mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:13,253,073...13,279,140
Ensembl chr10:13,253,380...13,279,101
|
|
G |
Cd22 |
CD22 molecule |
increases expression |
ISO |
propionaldehyde results in increased expression of CD22 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:86,116,376...86,132,782
Ensembl chr 1:86,117,459...86,132,322
|
|
G |
Cd33 |
CD33 molecule |
increases expression |
ISO |
propionaldehyde results in increased expression of CD33 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:93,935,418...93,940,452
Ensembl chr 1:93,930,971...93,950,149
|
|
G |
Cd40 |
CD40 molecule |
increases expression |
ISO |
propionaldehyde results in increased expression of CD40 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
|
|
G |
Cd47 |
Cd47 molecule |
increases expression |
ISO |
propionaldehyde results in increased expression of CD47 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:50,906,052...50,970,000
Ensembl chr11:50,906,177...50,969,425
|
|
G |
Cd52 |
CD52 molecule |
increases expression |
ISO |
propionaldehyde results in increased expression of CD52 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:146,319,789...146,321,348
Ensembl chr 5:146,319,969...146,321,348
|
|
G |
Cd55 |
CD55 molecule (Cromer blood group) |
increases expression |
ISO |
propionaldehyde results in increased expression of CD55 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:41,857,242...41,885,966
Ensembl chr13:41,857,395...41,885,831
|
|
G |
Cd68 |
Cd68 molecule |
increases expression |
ISO |
propionaldehyde results in increased expression of CD68 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:54,381,814...54,383,693
Ensembl chr10:54,381,815...54,383,697
|
|
G |
Cd70 |
Cd70 molecule |
increases expression |
ISO |
propionaldehyde results in increased expression of CD70 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:2,006,563...2,009,715
Ensembl chr 9:2,006,563...2,009,715
|
|
G |
Cd79b |
CD79b molecule |
increases expression |
ISO |
propionaldehyde results in increased expression of CD79B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:91,239,354...91,242,500
Ensembl chr10:91,239,356...91,242,625
|
|
G |
Cd82 |
Cd82 molecule |
increases expression |
ISO |
propionaldehyde results in increased expression of CD82 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:79,387,361...79,431,847
Ensembl chr 3:79,385,887...79,431,809
|
|
G |
Cd83 |
CD83 molecule |
increases expression |
ISO |
propionaldehyde results in increased expression of CD83 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:20,887,309...20,907,009
Ensembl chr17:20,887,309...20,907,083
|
|
G |
Cd8a |
CD8 subunit alpha |
increases expression |
ISO |
propionaldehyde results in increased expression of CD8A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:103,365,804...103,370,041
Ensembl chr 4:103,365,804...103,370,040
|
|
G |
Cdc20 |
cell division cycle 20 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CDC20 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:131,966,203...131,970,406
Ensembl chr 5:131,966,215...131,970,512
|
|
G |
Cdc25c |
cell division cycle 25C |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CDC25C mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185
|
|
G |
Cdc42bpg |
CDC42 binding protein kinase gamma |
increases expression |
ISO |
propionaldehyde results in increased expression of CDC42BPG mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:203,608,339...203,628,502
Ensembl chr 1:203,608,574...203,628,502
|
|
G |
Cdc45 |
cell division cycle 45 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CDC45 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:82,185,427...82,210,630
Ensembl chr11:82,185,473...82,210,619
|
|
G |
Cdca3 |
cell division cycle associated 3 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CDCA3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:157,634,775...157,638,799
Ensembl chr 4:157,634,928...157,638,799
|
|
G |
Cdca5 |
cell division cycle associated 5 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CDCA5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:203,378,550...203,392,027
Ensembl chr 1:203,378,577...203,392,023
|
|
G |
Cdca8 |
cell division cycle associated 8 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CDCA8 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:137,176,414...137,198,686
Ensembl chr 5:137,176,417...137,198,629
|
|
G |
Cdcp1 |
CUB domain containing protein 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CDCP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:122,828,685...122,865,345
Ensembl chr 8:122,828,685...122,865,388
|
|
G |
Cdh15 |
cadherin 15 |
increases expression |
ISO |
propionaldehyde results in increased expression of CDH15 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:50,903,757...50,927,151
Ensembl chr19:50,903,638...50,927,105
|
|
G |
Cdh16 |
cadherin 16 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CDH16 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:360,824...371,008
Ensembl chr19:360,824...371,007
|
|
G |
Cdh23 |
cadherin-related 23 |
increases expression |
ISO |
propionaldehyde results in increased expression of CDH23 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr20:28,240,643...28,622,490
Ensembl chr20:28,240,645...28,622,419
|
|
G |
Cdip1 |
cell death-inducing p53 target 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CDIP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:10,773,538...10,796,979
Ensembl chr10:10,774,705...10,796,980
|
|
G |
Cdiptos |
CDIP transferase, opposite strand |
increases expression |
ISO |
propionaldehyde results in increased expression of CDIPTOSP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:181,579,385...181,583,017
Ensembl chr 1:181,579,387...181,582,860
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CDK1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdk10 |
cyclin-dependent kinase 10 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CDK10 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:51,260,012...51,273,009
Ensembl chr19:51,261,356...51,269,078
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CDK2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdkn2c |
cyclin-dependent kinase inhibitor 2C |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CDKN2C mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:124,411,123...124,416,278
Ensembl chr 5:124,411,124...124,416,278
|
|
G |
Cdnf |
cerebral dopamine neurotrophic factor |
increases expression |
ISO |
propionaldehyde results in increased expression of CDNF mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:74,714,564...74,728,639
Ensembl chr17:74,713,564...74,728,639
|
|
G |
Cds1 |
CDP-diacylglycerol synthase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CDS1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:7,820,328...7,882,943
Ensembl chr14:7,820,351...7,882,681
|
|
G |
Cdt1 |
chromatin licensing and DNA replication factor 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CDT1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:50,620,713...50,625,659
Ensembl chr19:50,620,713...50,625,659
|
|
G |
Cdyl2 |
chromodomain Y-like 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CDYL2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:44,591,734...44,783,258
Ensembl chr19:44,597,459...44,783,022
|
|
G |
Cecr2 |
CECR2, histone acetyl-lysine reader |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CECR2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:153,890,310...153,998,078
Ensembl chr 4:153,890,206...153,993,451
|
|
G |
Celf4 |
CUGBP, Elav-like family member 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of CELF4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:16,786,578...17,065,045
Ensembl chr18:16,786,867...17,064,786
|
|
G |
Celf5 |
CUGBP, Elav-like family member 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of CELF5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:8,225,787...8,250,322
Ensembl chr 7:8,225,825...8,250,322
|
|
G |
Cemip |
cell migration inducing hyaluronidase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CEMIP mRNA |
CTD |
PMID:25014914 PMID:26079696 |
|
NCBI chr 1:137,906,921...138,062,430
Ensembl chr 1:137,908,920...138,062,415
|
|
G |
Cend1 |
cell cycle exit and neuronal differentiation 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CEND1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:196,525,153...196,528,152
Ensembl chr 1:196,523,920...196,528,302
|
|
G |
Cenpa |
centromere protein A |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CENPA mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:25,700,142...25,711,767
Ensembl chr 6:25,700,142...25,711,675
|
|
G |
Cenpe |
centromere protein E |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CENPE mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:223,637,035...223,695,692
Ensembl chr 2:223,636,998...223,695,669
|
|
G |
Cenpf |
centromere protein F |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CENPF mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:101,184,127...101,229,714
Ensembl chr13:101,184,127...101,229,669
|
|
G |
Cenph |
centromere protein H |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CENPH mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:31,896,675...31,910,179
Ensembl chr 2:31,894,667...31,910,154
|
|
G |
Cenpi |
centromere protein I |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CENPI mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:97,515,919...97,567,671
Ensembl chr X:97,515,972...97,567,657
|
|
G |
Cenpj |
centromere protein J |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CENPJ mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:30,627,206...30,690,384
Ensembl chr15:30,627,224...30,686,791
|
|
G |
Cenpk |
centromere protein K |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CENPK mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:35,360,390...35,421,372
Ensembl chr 2:35,360,132...35,385,706
|
|
G |
Cenpn |
centromere protein N |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CENPN mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:44,971,265...44,994,019
Ensembl chr19:44,968,308...44,994,012
|
|
G |
Cenpo |
centromere protein O |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CENPO mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:27,203,642...27,218,394
Ensembl chr 6:27,188,537...27,218,314
|
|
G |
Cenpp |
centromere protein P |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CENPP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:15,014,087...15,189,312
Ensembl chr17:15,014,058...15,189,304
|
|
G |
Cep78 |
centrosomal protein 78 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CEP78 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:213,246,183...213,275,275
Ensembl chr 1:213,246,187...213,275,181
|
|
G |
Cep85 |
centrosomal protein 85 |
increases methylation |
ISO |
propionaldehyde results in increased methylation of CEP85 gene |
CTD |
PMID:30002397 |
|
NCBI chr 5:146,356,571...146,404,155
Ensembl chr 5:146,356,576...146,404,060
|
|
G |
Cers1 |
ceramide synthase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CERS1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:19,097,309...19,112,519
Ensembl chr16:19,104,466...19,112,519
|
|
G |
Cfap251 |
cilia and flagella associated protein 251 |
increases expression |
ISO |
propionaldehyde results in increased expression of CFAP251 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:33,261,622...33,337,028
Ensembl chr12:33,261,476...33,293,932
|
|
G |
Cfap300 |
cilia and flagella associated protein 300 |
increases expression |
ISO |
propionaldehyde results in increased expression of CFAP300 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:5,180,180...5,198,840
Ensembl chr 8:5,180,675...5,198,807
|
|
G |
Cfap43 |
cilia and flagella associated protein 43 |
increases expression |
ISO |
propionaldehyde results in increased expression of CFAP43 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:246,625,259...246,712,438
Ensembl chr 1:246,625,262...246,712,443
|
|
G |
Cfap52 |
cilia and flagella associated protein 52 |
increases expression |
ISO |
propionaldehyde results in increased expression of CFAP52 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:52,613,761...52,654,922
Ensembl chr10:52,613,762...52,654,934
|
|
G |
Cfap58 |
cilia and flagella associated protein 58 |
increases expression |
ISO |
propionaldehyde results in increased expression of CFAP58 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:246,802,691...246,911,363
Ensembl chr 1:246,802,665...246,911,374
|
|
G |
Cfap70 |
cilia and flagella associated protein 70 |
increases expression |
ISO |
propionaldehyde results in increased expression of CFAP70 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:3,852,381...3,918,036
Ensembl chr15:3,852,509...3,918,014
|
|
G |
Cfap74 |
cilia and flagella associated protein 74 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CFAP74 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:165,970,611...166,046,068
Ensembl chr 5:165,979,805...166,046,071
|
|
G |
Cfap92 |
cilia and flagella associated protein 92 |
increases expression |
ISO |
propionaldehyde results in increased expression of CFAP92 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:120,126,565...120,181,575
Ensembl chr 4:120,126,567...120,181,546
|
|
G |
Cfb |
complement factor B |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CFB mRNA |
CTD |
PMID:26079696 |
|
NCBI chr20:3,970,643...3,976,510
Ensembl chr20:3,951,474...3,976,505
|
|
G |
Cfi |
complement factor I |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CFI mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:218,389,079...218,430,565
Ensembl chr 2:218,387,990...218,430,561
|
|
G |
Cga |
glycoprotein hormones, alpha polypeptide |
increases expression |
ISO |
propionaldehyde results in increased expression of CGA mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:49,486,915...49,499,192
Ensembl chr 5:49,487,068...49,499,191
|
|
G |
Cgn |
cingulin |
increases expression |
ISO |
propionaldehyde results in increased expression of CGN mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:182,308,389...182,335,747
Ensembl chr 2:182,308,714...182,334,645
|
|
G |
Cgnl1 |
cingulin-like 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CGNL1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:72,273,401...72,424,842
Ensembl chr 8:72,275,645...72,422,917
|
|
G |
Chac1 |
ChaC glutathione-specific gamma-glutamylcyclotransferase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CHAC1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:106,342,302...106,345,526
Ensembl chr 3:106,342,302...106,345,526
|
|
G |
Chchd10 |
coiled-coil-helix-coiled-coil-helix domain containing 10 |
increases expression |
ISO |
propionaldehyde results in increased expression of CHCHD10 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr20:12,725,839...12,727,638
Ensembl chr20:12,725,842...12,732,763
|
|
G |
Chd3 |
chromodomain helicase DNA binding protein 3 |
decreases expression increases methylation |
ISO |
propionaldehyde results in decreased expression of CHD3 mRNA propionaldehyde results in increased methylation of CHD3 gene |
CTD |
PMID:26079696 PMID:30002397 |
|
NCBI chr10:54,063,629...54,090,030
Ensembl chr10:54,063,629...54,090,047
|
|
G |
Chd5 |
chromodomain helicase DNA binding protein 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of CHD5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:162,848,273...162,898,997
Ensembl chr 5:162,848,394...162,896,291
|
|
G |
Chit1 |
chitinase 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CHIT1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:45,565,841...45,613,593
Ensembl chr13:45,593,845...45,613,592
|
|
G |
Chrac1 |
chromatin accessibility complex subunit 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CHRAC1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:105,013,047...105,016,435
Ensembl chr 7:105,013,015...105,017,136
|
|
G |
Chrdl2 |
chordin-like 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CHRDL2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:154,343,201...154,370,651
Ensembl chr 1:154,343,201...154,370,640
|
|
G |
Chrm3 |
cholinergic receptor, muscarinic 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of CHRM3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:60,005,137...60,467,250
Ensembl chr17:60,005,202...60,467,278
|
|
G |
Chrna3 |
cholinergic receptor nicotinic alpha 3 subunit |
increases expression |
ISO |
propionaldehyde results in increased expression of CHRNA3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:55,401,668...55,415,165
Ensembl chr 8:55,401,702...55,415,165
|
|
G |
Chrna7 |
cholinergic receptor nicotinic alpha 7 subunit |
increases expression |
ISO |
propionaldehyde results in increased expression of CHRNA7 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:116,711,559...116,837,269
Ensembl chr 1:116,714,711...116,837,240
|
|
G |
Chrnb4 |
cholinergic receptor nicotinic beta 4 subunit |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CHRNB4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:55,417,583...55,437,027
Ensembl chr 8:55,418,313...55,437,027
|
|
G |
Chst1 |
carbohydrate sulfotransferase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CHST1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:78,552,059...78,574,740
Ensembl chr 3:78,548,525...78,574,883
|
|
G |
Chst11 |
carbohydrate sulfotransferase 11 |
increases expression |
ISO |
propionaldehyde results in increased expression of CHST11 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:20,524,535...20,743,008
Ensembl chr 7:20,528,100...20,743,111
|
|
G |
Chst2 |
carbohydrate sulfotransferase 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CHST2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:95,960,067...95,966,312
Ensembl chr 8:95,959,826...95,966,955
|
|
G |
Chst5 |
carbohydrate sulfotransferase 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of CHST6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:39,860,729...39,881,019
Ensembl chr19:39,860,501...39,881,064
|
|
G |
Cib4 |
calcium and integrin binding family member 4 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CIB4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:25,842,605...25,903,509
Ensembl chr 6:25,842,622...25,917,206
|
|
G |
Cibar2 |
CBY1 interacting BAR domain containing 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CIBAR2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:48,217,617...48,229,418
Ensembl chr19:48,215,486...48,229,404
|
|
G |
Cideb |
cell death-inducing DFFA-like effector b |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CIDEB mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:29,252,208...29,256,482
Ensembl chr15:29,252,213...29,256,605
|
|
G |
Cimip6 |
ciliary microtubule inner protein 6 |
increases expression |
ISO |
propionaldehyde results in increased expression of CIMIP6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:104,145,818...104,178,973
Ensembl chr14:104,145,818...104,178,973
|
|
G |
Cip2a |
cellular inhibitor of PP2A |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CIP2A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:51,792,143...51,823,016
Ensembl chr11:51,795,024...51,822,938
|
|
G |
Cit |
citron rho-interacting serine/threonine kinase |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CIT mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:40,603,073...40,764,846
Ensembl chr12:40,605,563...40,763,860
|
|
G |
Cited1 |
Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CITED1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:67,350,376...67,355,072
Ensembl chr X:67,350,373...67,355,162
|
|
G |
Cited4 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of CITED4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:134,246,936...134,247,827
Ensembl chr 5:134,246,682...134,248,135
|
|
G |
Ckap2l |
cytoskeleton associated protein 2-like |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CKAP2L mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:116,497,186...116,524,302
Ensembl chr 3:116,498,022...116,524,366
|
|
G |
Ckb |
creatine kinase B |
increases expression |
ISO |
propionaldehyde results in increased expression of CKB mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:130,729,420...130,732,301
Ensembl chr 6:130,729,423...130,732,315
|
|
G |
Cks1b |
CDC28 protein kinase regulatory subunit 1B |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CKS1B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:174,833,025...174,837,614
Ensembl chr 2:174,833,050...174,837,636
|
|
G |
Clcn4 |
chloride voltage-gated channel 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of CLCN4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:23,729,194...23,795,391
Ensembl chr X:23,729,338...23,793,238
|
|
G |
Cldn22 |
claudin 22 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CLDN22 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:44,422,344...44,423,370
Ensembl chr16:44,422,345...44,423,354
|
|
G |
Cldn3 |
claudin 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of CLDN3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:21,708,538...21,710,010
Ensembl chr12:21,708,398...21,711,001
|
|
G |
Cldn4 |
claudin 4 |
increases expression decreases expression |
ISO |
propionaldehyde results in increased expression of CLDN4 mRNA propionaldehyde results in decreased expression of CLDN4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:21,751,638...21,753,436
Ensembl chr12:21,751,331...21,753,436
|
|
G |
Clic3 |
chloride intracellular channel 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of CLIC3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:8,271,416...8,274,023
Ensembl chr 3:8,272,097...8,274,018
|
|
G |
Clmp |
CXADR-like membrane protein |
increases expression |
ISO |
propionaldehyde results in increased expression of CLMP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:41,060,527...41,168,841
Ensembl chr 8:41,060,799...41,168,838
|
|
G |
Clrn3 |
clarin 3 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CLRN3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:190,319,025...190,334,648
Ensembl chr 1:190,319,026...190,334,648
|
|
G |
Cltrn |
collectrin, amino acid transport regulator |
increases expression |
ISO |
propionaldehyde results in increased expression of CLTRN mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:30,361,967...30,395,264
Ensembl chr X:30,361,967...30,395,349
|
|
G |
Cnih2 |
cornichon family AMPA receptor auxiliary protein 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CNIH2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:202,399,416...202,405,110
Ensembl chr 1:202,399,419...202,405,089
|
|
G |
Cnih3 |
cornichon family AMPA receptor auxiliary protein 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of CNIH3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:93,016,707...93,208,168
Ensembl chr13:93,099,784...93,208,121
|
|
G |
Cnn1 |
calponin 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CNN1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:20,632,434...20,641,097
Ensembl chr 8:20,632,338...20,641,098
|
|
G |
Cnn2 |
calponin 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CNN2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:9,712,505...9,719,678
Ensembl chr 7:9,712,516...9,719,656
|
|
G |
Cobl |
cordon-bleu WH2 repeat protein |
increases expression |
ISO |
propionaldehyde results in increased expression of COBL mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:86,828,137...87,060,682
Ensembl chr14:86,828,139...87,060,800
|
|
G |
Col13a1 |
collagen type XIII alpha 1 chain |
increases expression |
ISO |
propionaldehyde results in increased expression of COL13A1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr20:29,783,965...29,924,116
Ensembl chr20:29,783,965...29,924,032
|
|
G |
Col16a1 |
collagen type XVI alpha 1 chain |
increases expression |
ISO |
propionaldehyde results in increased expression of COL16A1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:142,388,376...142,442,825
Ensembl chr 5:142,388,426...142,442,825
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
increases expression |
ISO |
propionaldehyde results in increased expression of COL1A1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col26a1 |
collagen type XXVI alpha 1 chain |
decreases expression |
ISO |
propionaldehyde results in decreased expression of COL26A1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:19,792,693...19,938,556
Ensembl chr12:19,792,728...19,938,556
|
|
G |
Col28a1 |
collagen type XXVIII alpha 1 chain |
increases expression |
ISO |
propionaldehyde results in increased expression of COL28A1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:36,069,980...36,223,128
Ensembl chr 4:36,069,970...36,223,220
|
|
G |
Col5a1 |
collagen type V alpha 1 chain |
increases expression |
ISO |
propionaldehyde results in increased expression of COL5A1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:11,208,429...11,356,715
Ensembl chr 3:11,208,512...11,354,588
|
|
G |
Col6a2 |
collagen type VI alpha 2 chain |
increases expression |
ISO |
propionaldehyde results in increased expression of COL6A2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr20:12,021,676...12,049,425
Ensembl chr20:12,021,767...12,057,564
|
|
G |
Colec12 |
collectin sub-family member 12 |
increases expression |
ISO |
propionaldehyde results in increased expression of COLEC12 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:732,950...920,620
Ensembl chr18:732,950...920,618
|
|
G |
Coro6 |
coronin 6 |
increases expression |
ISO |
propionaldehyde results in increased expression of CORO6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:62,311,552...62,319,659
Ensembl chr10:62,311,660...62,319,659
|
|
G |
Cotl1 |
coactosin-like F-actin binding protein 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of COTL1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:47,871,689...47,906,010
Ensembl chr19:47,871,694...47,911,689
|
|
G |
Cox17 |
cytochrome c oxidase copper chaperone COX17 |
increases methylation |
ISO |
propionaldehyde results in increased methylation of COX17 gene |
CTD |
PMID:30002397 |
|
NCBI chr11:62,400,733...62,406,507
|
|
G |
Cox6a2 |
cytochrome c oxidase subunit 6A2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of COX6A2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:182,788,528...182,790,746
Ensembl chr 1:182,788,528...182,789,274
|
|
G |
Cox8c |
cytochrome c oxidase subunit 8C |
increases expression |
ISO |
propionaldehyde results in increased expression of COX8C mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:122,028,566...122,029,889
Ensembl chr 6:122,028,566...122,029,889
|
|
G |
Cp |
ceruloplasmin |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
|
|
G |
Cpa4 |
carboxypeptidase A4 |
increases expression |
ISO |
propionaldehyde results in increased expression of CPA4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:59,188,284...59,212,255
Ensembl chr 4:59,188,284...59,212,255
|
|
G |
Cpamd8 |
C3 and PZP-like, alpha-2-macroglobulin domain containing 8 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CPAMD8 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:155,332,827...155,413,098
Ensembl chr 4:155,332,827...155,413,117
|
|
G |
Cplx2 |
complexin 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CPLX2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:10,219,577...10,292,835
Ensembl chr17:10,222,347...10,293,855
|
|
G |
Cpn1 |
carboxypeptidase N subunit 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CPN1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:242,844,575...242,873,465
Ensembl chr 1:242,844,212...242,873,465
|
|
G |
Cpq |
carboxypeptidase Q |
decreases expression |
ISO |
propionaldehyde results in decreased expression of PGCP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:64,264,025...64,830,867
Ensembl chr 7:64,264,081...64,724,546
|
|
G |
Cpt1c |
carnitine palmitoyltransferase 1c |
increases expression |
ISO |
propionaldehyde results in increased expression of CPT1C mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:95,442,814...95,457,347
Ensembl chr 1:95,442,817...95,457,342
|
|
G |
Cpxm2 |
carboxypeptidase X (M14 family), member 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CPXM2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:186,836,797...186,947,222
Ensembl chr 1:186,836,797...186,947,220
|
|
G |
Crabp1 |
cellular retinoic acid binding protein 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CRABP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:55,138,363...55,159,360
Ensembl chr 8:55,151,285...55,159,360
|
|
G |
Crabp2 |
cellular retinoic acid binding protein 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CRABP2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:173,417,004...173,421,352
Ensembl chr 2:173,416,857...173,421,379
|
|
G |
Crb1 |
crumbs cell polarity complex component 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CRB1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:50,801,484...50,989,261
Ensembl chr13:50,800,959...50,989,261
|
|
G |
Creb3l3 |
cAMP responsive element binding protein 3-like 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of CREB3L3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:8,622,614...8,631,053
Ensembl chr 7:8,622,614...8,631,048
|
|
G |
Crebbp |
CREB binding protein |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CREBBP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
|
|
G |
Crhr1 |
corticotropin releasing hormone receptor 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CRHR1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:89,040,186...89,083,481
Ensembl chr10:89,040,203...89,083,481
|
|
G |
Crip2 |
cysteine-rich protein 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CRIP2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:132,221,120...132,226,066
Ensembl chr 6:132,221,082...132,226,065
|
|
G |
Crip3 |
cysteine-rich protein 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of CRIP3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:14,554,450...14,557,344
Ensembl chr 9:14,554,450...14,557,302
|
|
G |
Crlf1 |
cytokine receptor-like factor 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CRLF1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:18,924,722...18,936,049
Ensembl chr16:18,924,722...18,935,997
|
|
G |
Crtac1 |
cartilage acidic protein 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CRTAC1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:241,091,679...241,233,677
Ensembl chr 1:241,078,864...241,233,421
|
|
G |
Crx |
cone-rod homeobox |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CRX mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:76,539,812...76,553,694
Ensembl chr 1:76,540,141...76,545,818
|
|
G |
Crybg1 |
crystallin beta-gamma domain containing 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CRYBG1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr20:47,425,030...47,496,918
Ensembl chr20:47,426,183...47,621,392
|
|
G |
Crybg2 |
crystallin beta-gamma domain containing 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CRYBG2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:146,286,406...146,318,417
Ensembl chr 5:146,286,925...146,323,666
|
|
G |
Crym |
crystallin, mu |
increases expression |
ISO |
propionaldehyde results in increased expression of CRYM mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:174,560,423...174,575,660
Ensembl chr 1:174,560,416...174,575,633
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
increases expression |
ISO |
propionaldehyde results in increased expression of CSF1R mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
|
|
G |
Csf2ra |
colony stimulating factor 2 receptor subunit alpha |
increases expression |
ISO |
propionaldehyde results in increased expression of CSF2RA mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:98,089...103,261
Ensembl chr14:89,172...103,128
|
|
G |
Csf3 |
colony stimulating factor 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of CSF3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
|
|
G |
Csrp1 |
cysteine and glycine-rich protein 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CSRP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:47,158,171...47,179,388
Ensembl chr13:47,167,789...47,179,384
|
|
G |
Csta |
cystatin A |
increases expression |
ISO |
propionaldehyde results in increased expression of CSTA mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:64,620,483...64,631,488
Ensembl chr11:64,620,483...64,631,488
|
|
G |
Ctdsp1 |
CTD small phosphatase 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CTDSP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:75,973,694...75,979,298
Ensembl chr 9:75,973,962...75,979,297
|
|
G |
Cthrc1 |
collagen triple helix repeat containing 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CTHRC1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:70,122,474...70,132,756
Ensembl chr 7:70,122,474...70,132,756
|
|
G |
Ctnnd2 |
catenin delta 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CTNND2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:81,168,525...82,016,495
Ensembl chr 2:81,167,117...82,015,764
|
|
G |
Ctps1 |
CTP synthase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CTPS1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:134,125,022...134,154,155
Ensembl chr 5:134,125,025...134,154,180
|
|
G |
Ctsh |
cathepsin H |
increases expression |
ISO |
propionaldehyde results in increased expression of CTSH mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:90,608,941...90,627,824
Ensembl chr 8:90,608,941...90,627,824
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CXCL1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
increases expression |
ISO |
propionaldehyde results in increased expression of CXCL10 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CXCL12 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
|
|
G |
Cxcl14 |
C-X-C motif chemokine ligand 14 |
increases expression |
ISO |
propionaldehyde results in increased expression of CXCL14 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:8,317,930...8,325,956
Ensembl chr17:8,317,933...8,324,839
|
|
G |
Cxcl17 |
C-X-C motif chemokine ligand 17 |
increases expression |
ISO |
propionaldehyde results in increased expression of CXCL17 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:80,984,751...80,996,842
Ensembl chr 1:80,984,964...80,996,726
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CXCL2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of CXCL1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of CXCR4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
|
|
G |
Cyb561 |
cytochrome b-561 |
increases expression |
ISO |
propionaldehyde results in increased expression of CYB561 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:90,878,052...90,888,734
Ensembl chr10:90,878,054...90,884,787
|
|
G |
Cyb5r1 |
cytochrome b5 reductase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CYB5R1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:45,849,017...45,855,458
Ensembl chr13:45,849,091...45,855,458
|
|
G |
Cyb5r2 |
cytochrome b5 reductase 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CYB5R2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:161,655,862...161,664,359
Ensembl chr 1:161,655,864...161,664,097
|
|
G |
Cyfip2 |
cytoplasmic FMR1 interacting protein 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of CYFIP2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:30,621,318...30,741,113
Ensembl chr10:30,621,318...30,741,113
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CYP1A1 mRNA |
CTD |
PMID:25014914 PMID:26079696 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CYP26A1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:235,471,368...235,475,204
Ensembl chr 1:235,471,298...235,475,204
|
|
G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
increases expression |
ISO |
propionaldehyde results in increased expression of CYP2C18 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
|
|
G |
Cyp2g1 |
cytochrome P450, family 2, subfamily g, polypeptide 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CYP2G1P mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:82,145,635...82,156,862
Ensembl chr 1:82,145,073...82,156,828
|
|
G |
Cyp2j4 |
cytochrome P450, family 2, subfamily j, polypeptide 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of CYP2J2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:111,179,981...111,207,490
Ensembl chr 5:111,178,703...111,244,794
|
|
G |
Cyria |
CYFIP related Rac1 interactor A |
increases expression |
ISO |
propionaldehyde results in increased expression of CYRIA mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:35,045,208...35,150,669
Ensembl chr 6:35,045,208...35,150,668
|
|
G |
Cysrt1 |
cysteine rich tail 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of CYSRT1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:8,054,195...8,057,846
Ensembl chr 3:8,053,482...8,059,721
|
|
G |
Cyth4 |
cytohesin 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of CYTH4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:110,152,232...110,176,726
Ensembl chr 7:110,152,272...110,176,741
|
|
G |
Cytip |
cytohesin 1 interacting protein |
decreases expression |
ISO |
propionaldehyde results in decreased expression of CYTIP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:42,698,058...42,774,955
Ensembl chr 3:42,698,768...42,725,993
|
|
G |
D430041D05Rikl |
RIKEN cDNA D430041D05 gene like |
increases expression |
ISO |
propionaldehyde results in increased expression of KIAA1549L mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:90,506,559...90,782,427
Ensembl chr 3:90,510,942...90,781,894
|
|
G |
Dact3 |
dishevelled-binding antagonist of beta-catenin 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of DACT3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:77,546,900...77,558,631
Ensembl chr 1:77,546,900...77,558,630
|
|
G |
Dapl1 |
death associated protein-like 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of DAPL1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:43,960,993...43,980,940
Ensembl chr 3:43,960,810...43,980,940
|
|
G |
Daw1 |
dynein assembly factor with WD repeats 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of DAW1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:84,435,552...84,472,632
Ensembl chr 9:84,435,552...84,472,635
|
|
G |
Dcbld2 |
discoidin, CUB and LCCL domain containing 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of DCBLD2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:42,125,525...42,179,927
Ensembl chr11:42,125,787...42,179,697
|
|
G |
Dclk1 |
doublecortin-like kinase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of DCLK1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:139,417,234...139,710,956
Ensembl chr 2:139,417,163...139,710,956
|
|
G |
Dcst2 |
DC-STAMP domain containing 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DCST2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:174,781,806...174,795,834
Ensembl chr 2:174,781,902...174,795,832
|
|
G |
Ddc |
dopa decarboxylase |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DDC mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208
|
|
G |
Ddo |
D-aspartate oxidase |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DDO mRNA |
CTD |
PMID:26079696 |
|
NCBI chr20:44,090,823...44,109,962
Ensembl chr20:44,090,914...44,133,095
|
|
G |
Defb105b |
defensin beta 105B |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DEFB105B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:70,725,687...70,728,859
Ensembl chr16:70,725,701...70,728,143 Ensembl chr16:70,725,701...70,728,143
|
|
G |
Defb23 |
defensin beta 23 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DEFB129 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:140,923,474...140,927,715
Ensembl chr 3:140,923,474...140,927,686
|
|
G |
Dennd1c |
DENN domain containing 1C |
increases expression |
ISO |
propionaldehyde results in increased expression of DENND1C mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:1,904,040...1,916,329
Ensembl chr 9:1,904,045...1,916,187
|
|
G |
Dennd2c |
DENN domain containing 2C |
increases expression |
ISO |
propionaldehyde results in increased expression of DENND2C mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:190,622,357...190,690,489
Ensembl chr 2:190,622,940...190,690,488
|
|
G |
Dennd2d |
DENN domain containing 2D |
increases expression |
ISO |
propionaldehyde results in increased expression of DENND2D mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:193,973,231...193,992,275
Ensembl chr 2:193,973,231...193,992,270
|
|
G |
Depdc1 |
DEP domain containing 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DEPDC1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:248,684,508...248,717,951
Ensembl chr 2:248,684,523...248,717,951
|
|
G |
Depdc1b |
DEP domain containing 1B |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DEPDC1B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:39,891,163...39,963,779
Ensembl chr 2:39,891,481...39,963,779
|
|
G |
Dgka |
diacylglycerol kinase, alpha |
increases expression |
ISO |
propionaldehyde results in increased expression of DGKA mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:1,148,734...1,175,324
Ensembl chr 7:1,148,735...1,175,110
|
|
G |
Dhdh |
dihydrodiol dehydrogenase |
increases expression |
ISO |
propionaldehyde results in increased expression of DHDH mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:95,954,361...95,965,262
Ensembl chr 1:95,953,092...95,965,197
|
|
G |
Dhfr |
dihydrofolate reductase |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DHFR mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:23,585,876...23,611,199
Ensembl chr 2:23,586,031...23,613,713
|
|
G |
Dhrs2 |
dehydrogenase/reductase 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of DHRS2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:28,688,881...28,703,646
Ensembl chr15:28,688,940...28,703,644
|
|
G |
Dhrs9 |
dehydrogenase/reductase 9 |
increases expression |
ISO |
propionaldehyde results in increased expression of DHRS9 mRNA |
CTD |
PMID:25014914 PMID:26079696 |
|
NCBI chr 3:54,147,834...54,170,052
Ensembl chr 3:54,147,803...54,220,241
|
|
G |
Dhx58 |
DEXH-box helicase 58 |
increases expression |
ISO |
propionaldehyde results in increased expression of DHX58 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:85,620,352...85,631,776
Ensembl chr10:85,620,357...85,631,525
|
|
G |
Diaph3 |
diaphanous-related formin 3 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DIAPH3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:62,543,375...63,013,060
Ensembl chr15:62,543,375...63,012,975
|
|
G |
Dipk1b |
divergent protein kinase domain 1B |
increases expression |
ISO |
propionaldehyde results in increased expression of DIPK1B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:9,455,914...9,464,169
Ensembl chr 3:9,456,409...9,464,161
|
|
G |
Diras1 |
DIRAS family GTPase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of DIRAS1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:8,687,964...8,692,828
Ensembl chr 7:8,687,942...8,693,831
|
|
G |
Disc1 |
DISC1 scaffold protein |
increases expression |
ISO |
propionaldehyde results in increased expression of DISC1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:53,014,201...53,223,617
Ensembl chr19:53,014,616...53,219,778
|
|
G |
Dkk3 |
dickkopf WNT signaling pathway inhibitor 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of DKK3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:166,237,969...166,281,271
Ensembl chr 1:166,238,238...166,280,590
|
|
G |
Dlgap5 |
DLG associated protein 5 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DLGAP5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:20,633,964...20,664,569
Ensembl chr15:20,633,966...20,664,518
|
|
G |
Dll1 |
delta like canonical Notch ligand 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of DLL1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:56,312,062...56,320,177
Ensembl chr 1:56,312,066...56,320,179
|
|
G |
Dlx2 |
distal-less homeobox 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of DLX2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:56,370,238...56,373,581
Ensembl chr 3:56,370,483...56,373,597
|
|
G |
Dmd |
dystrophin |
increases expression |
ISO |
propionaldehyde results in increased expression of DMD mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:47,272,324...49,504,219
Ensembl chr X:47,272,331...49,504,207
|
|
G |
Dmkn |
dermokine |
increases expression |
ISO |
propionaldehyde results in increased expression of DMKN mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:86,013,237...86,031,243
Ensembl chr 1:86,014,188...86,030,006
|
|
G |
Dnaaf11 |
dynein axonemal assembly factor 11 |
increases expression |
ISO |
propionaldehyde results in increased expression of DNAAF11 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:98,141,525...98,245,906
Ensembl chr 7:98,144,763...98,245,837
|
|
G |
Dnaaf2 |
dynein, axonemal, assembly factor 2 |
increases methylation |
ISO |
propionaldehyde results in increased methylation of DNAAF2 gene |
CTD |
PMID:30002397 |
|
NCBI chr 6:87,661,101...87,670,267
Ensembl chr 6:87,660,821...87,670,199
|
|
G |
Dnaaf3 |
dynein, axonemal, assembly factor 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of DNAAF3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:69,291,300...69,299,365
Ensembl chr 1:69,291,454...69,299,344
|
|
G |
Dnah10 |
dynein, axonemal, heavy chain 10 |
increases expression |
ISO |
propionaldehyde results in increased expression of DNAH10 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:31,823,451...31,946,857
Ensembl chr12:31,822,733...32,007,069
|
|
G |
Dnah12 |
dynein, axonemal, heavy chain 12 |
increases expression |
ISO |
propionaldehyde results in increased expression of DNAH12 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:1,936,354...2,092,663
Ensembl chr16:1,937,817...2,092,664
|
|
G |
Dnah7 |
dynein, axonemal, heavy chain 7 |
increases expression |
ISO |
propionaldehyde results in increased expression of DNAH7 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:54,960,235...55,266,529
Ensembl chr 9:54,960,440...55,262,297
|
|
G |
Dnai1 |
dynein, axonemal, intermediate chain 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of DNAI1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:56,730,179...56,800,926
Ensembl chr 5:56,730,179...56,800,925
|
|
G |
Dnai3 |
dynein axonemal intermediate chain 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of DNAI3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:234,947,910...235,006,173
Ensembl chr 2:234,929,677...235,006,173
|
|
G |
Dnai4 |
dynein axonemal intermediate chain 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of DNAI4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:117,787,398...117,876,216
Ensembl chr 5:117,788,464...117,876,127
|
|
G |
Dnai7 |
dynein axonemal intermediate chain 7 |
increases expression |
ISO |
propionaldehyde results in increased expression of DNAI7 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:178,143,499...178,179,871
Ensembl chr 4:178,143,500...178,179,980
|
|
G |
Dnajc5b |
DnaJ heat shock protein family (Hsp40) member C5 beta |
increases expression |
ISO |
propionaldehyde results in increased expression of DNAJC5B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:101,973,726...102,066,275
Ensembl chr 2:101,973,793...102,066,275
|
|
G |
Dner |
delta/notch-like EGF repeat containing |
increases expression |
ISO |
propionaldehyde results in increased expression of DNER mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:85,586,985...85,902,461
Ensembl chr 9:85,586,987...85,902,637
|
|
G |
Dnm3 |
dynamin 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of DNM3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:74,359,043...74,838,135
Ensembl chr13:74,359,213...74,838,108
|
|
G |
Dock4 |
dedicator of cytokinesis 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of DOCK4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:57,512,929...57,902,597
Ensembl chr 6:57,512,908...57,901,855
|
|
G |
Dock5 |
dedicator of cytokinesis 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of DOCK5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:41,979,728...42,158,733
Ensembl chr15:41,979,729...42,158,649
|
|
G |
Dpep1 |
dipeptidase 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DPEP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:51,209,831...51,237,004
Ensembl chr19:51,219,660...51,235,257
|
|
G |
Dpep3 |
dipeptidase 3 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DPEP3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:33,868,229...33,876,609
Ensembl chr19:33,868,242...33,873,896
|
|
G |
Dpp4 |
dipeptidylpeptidase 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of DPP4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:46,962,233...47,043,870
Ensembl chr 3:46,962,243...47,043,901
|
|
G |
Dpyd |
dihydropyrimidine dehydrogenase |
increases expression |
ISO |
propionaldehyde results in increased expression of DPYD mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982
|
|
G |
Dpysl5 |
dihydropyrimidinase-like 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of DPYSL5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:25,575,104...25,659,422
Ensembl chr 6:25,575,104...25,659,422
|
|
G |
Drc12 |
dynein regulatory complex subunit 12 homolog |
increases expression |
ISO |
propionaldehyde results in increased expression of DRC12 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:44,576,528...44,584,345
Ensembl chr 8:44,577,836...44,584,338
|
|
G |
Drd3 |
dopamine receptor D3 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DRD3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:56,879,689...56,931,901
Ensembl chr11:56,879,689...56,940,596
|
|
G |
Drgx |
dorsal root ganglia homeobox |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DRGX mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:7,854,849...7,884,404
Ensembl chr16:7,854,849...7,900,600
|
|
G |
Dscaml1 |
DS cell adhesion molecule-like 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DSCAML1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:45,740,298...46,057,322
Ensembl chr 8:45,740,298...46,057,320
|
|
G |
Dscc1 |
DNA replication and sister chromatid cohesion 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DSCC1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:86,482,588...86,498,212
Ensembl chr 7:86,482,588...86,498,212
|
|
G |
Dsn1 |
DSN1 component of MIS12 kinetochore complex |
decreases expression |
ISO |
propionaldehyde results in decreased expression of DSN1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:145,652,741...145,668,025
Ensembl chr 3:145,652,737...145,665,856
|
|
G |
Dtx1 |
deltex E3 ubiquitin ligase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of DTX1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:35,849,647...35,880,835
Ensembl chr12:35,849,617...35,880,838
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of DUSP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:16,680,478...16,683,275
|
|
G |
Dusp26 |
dual specificity phosphatase 26 |
increases expression |
ISO |
propionaldehyde results in increased expression of DUSP26 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:61,041,784...61,049,319
Ensembl chr16:61,041,792...61,049,051
|
|
G |
Dusp6 |
dual specificity phosphatase 6 |
increases expression |
ISO |
propionaldehyde results in increased expression of DUSP6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
|
|
G |
Dydc2 |
DPY30 domain containing 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of DYDC2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:16,928,172...16,941,950
Ensembl chr16:16,928,194...16,936,164
|
|
G |
E2f7 |
E2F transcription factor 7 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of E2F7 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:46,150,533...46,192,739
Ensembl chr 7:46,151,293...46,192,734
|
|
G |
E2f8 |
E2F transcription factor 8 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of E2F8 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098
|
|
G |
Ebi3 |
Epstein-Barr virus induced 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of EBI3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:774,252...787,544
Ensembl chr 9:783,617...787,544
|
|
G |
Ecm1 |
extracellular matrix protein 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ECM1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:183,287,491...183,292,729
Ensembl chr 2:183,287,322...183,292,671
|
|
G |
Edn2 |
endothelin 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of EDN2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:133,751,316...133,756,814
Ensembl chr 5:133,751,217...133,756,814
|
|
G |
Edn3 |
endothelin 3 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of EDN3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:163,562,307...163,586,636
Ensembl chr 3:163,562,520...163,585,093
|
|
G |
Eef1a2 |
eukaryotic translation elongation factor 1 alpha 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of EEF1A2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:168,265,893...168,275,071
Ensembl chr 3:168,195,357...168,275,071
|
|
G |
Efcab10 |
EF-hand calcium binding domain 10 |
increases expression |
ISO |
propionaldehyde results in increased expression of EFCAB10 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:50,004,479...50,011,398
Ensembl chr 6:50,004,479...50,011,398
|
|
G |
Efcab11 |
EF-hand calcium binding domain 11 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of EFCAB11 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:119,008,908...119,162,994
Ensembl chr 6:119,008,919...119,162,046
|
|
G |
Efcab2 |
EF-hand calcium binding domain 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of EFCAB2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:90,152,002...90,237,918
Ensembl chr13:90,152,185...90,238,218
|
|
G |
Efemp1 |
EGF containing fibulin extracellular matrix protein 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of EFEMP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:102,610,813...102,690,027
Ensembl chr14:102,610,908...102,690,018
|
|
G |
Efhd1 |
EF-hand domain family, member D1 |
increases expression |
ISO |
propionaldehyde results in increased expression of EFHD1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:87,938,259...87,984,917
Ensembl chr 9:87,938,284...87,984,917
|
|
G |
Efnb2 |
ephrin B2 |
increases expression |
ISO |
propionaldehyde results in increased expression of EFNB2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:80,783,389...80,827,420
Ensembl chr16:80,783,417...80,824,391
|
|
G |
Efnb3 |
ephrin B3 |
increases expression |
ISO |
propionaldehyde results in increased expression of EFNB3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:54,274,506...54,281,951
Ensembl chr10:54,274,506...54,280,471
|
|
G |
Efr3b |
EFR3 homolog B |
increases expression |
ISO |
propionaldehyde results in increased expression of EFR3B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:26,947,436...27,021,113
Ensembl chr 6:26,948,540...27,020,933
|
|
G |
Egr2 |
early growth response 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of EGR2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr20:21,051,270...21,056,322
Ensembl chr20:21,051,277...21,055,562
|
|
G |
Elapor1 |
endosome-lysosome associated apoptosis and autophagy regulator 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ELAPOR1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:196,089,199...196,169,055
Ensembl chr 2:196,091,646...196,168,716
|
|
G |
Elfn2 |
extracellular leucine-rich repeat and fibronectin type III domain containing 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of ELFN2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:110,220,293...110,272,770
Ensembl chr 7:110,225,919...110,272,433
|
|
G |
Elmod1 |
ELMO domain containing 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ELMOD1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:54,298,363...54,355,348
Ensembl chr 8:54,298,363...54,355,140
|
|
G |
Elovl3 |
ELOVL fatty acid elongase 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of ELOVL3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:244,997,287...245,001,115
Ensembl chr 1:244,997,287...245,001,115
|
|
G |
Elovl4 |
ELOVL fatty acid elongase 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of ELOVL4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:84,702,916...84,729,466
Ensembl chr 8:84,702,362...84,729,697
|
|
G |
Eme1 |
essential meiotic structure-specific endonuclease 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of EME1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:79,586,718...79,595,515
Ensembl chr10:79,586,729...79,595,435
|
|
G |
Emp1 |
epithelial membrane protein 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of EMP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:168,212,901...168,233,039
Ensembl chr 4:168,212,861...168,232,904
|
|
G |
Enho |
energy homeostasis associated |
increases expression |
ISO |
propionaldehyde results in increased expression of ENHO mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:56,800,980...56,802,777
Ensembl chr 5:56,800,980...56,802,777
|
|
G |
Eno2 |
enolase 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of ENO2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
|
|
G |
Eno3 |
enolase 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of ENO3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:55,370,531...55,375,921
Ensembl chr10:55,366,975...55,375,921
|
|
G |
Enox1 |
ecto-NOX disulfide-thiol exchanger 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ENOX1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:52,517,833...53,079,752
Ensembl chr15:52,515,178...53,079,749
|
|
G |
Entrep1 |
endosomal transmembrane epsin interactor 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ENTREP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:221,592,500...221,646,603
Ensembl chr 1:221,592,503...221,646,758
|
|
G |
Eomes |
eomesodermin |
increases expression |
ISO |
propionaldehyde results in increased expression of EOMES mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:118,181,340...118,189,186
Ensembl chr 8:118,181,777...118,188,316
|
|
G |
Epc2 |
enhancer of polycomb homolog 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of EPC2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:33,867,219...33,967,908
Ensembl chr 3:33,867,219...33,967,150
|
|
G |
Epcip |
exosomal polycystin 1 interacting protein |
decreases expression |
ISO |
propionaldehyde results in decreased expression of EPCIP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:30,307,842...30,325,829
Ensembl chr11:30,310,350...30,325,439
|
|
G |
Epha10 |
EPH receptor A10 |
increases expression |
ISO |
propionaldehyde results in increased expression of EPHA10 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:137,139,588...137,175,637
Ensembl chr 5:137,140,735...137,174,157
|
|
G |
Epha2 |
Eph receptor A2 |
increases expression |
ISO |
propionaldehyde results in increased expression of EPHA2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:153,605,644...153,634,115
Ensembl chr 5:153,605,644...153,634,117
|
|
G |
Ephb2 |
Eph receptor B2 |
increases expression |
ISO |
propionaldehyde results in increased expression of EPHB2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:148,889,574...149,077,027
Ensembl chr 5:148,897,246...149,077,059
|
|
G |
Ephb3 |
Eph receptor B3 |
increases expression |
ISO |
propionaldehyde results in increased expression of EPHB3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:79,840,668...79,859,345
Ensembl chr11:79,840,668...79,859,370
|
|
G |
Epn3 |
epsin 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of EPN3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:79,438,978...79,449,516
Ensembl chr10:79,438,978...79,447,356
|
|
G |
Ereg |
epiregulin |
increases expression |
ISO |
propionaldehyde results in increased expression of EREG mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:17,027,287...17,041,062
Ensembl chr14:17,027,287...17,041,062
|
|
G |
Ergic1 |
endoplasmic reticulum-golgi intermediate compartment 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of ERGIC1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:16,531,192...16,626,974
Ensembl chr10:16,531,194...16,626,957
|
|
G |
Erich4 |
glutamate-rich 4 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ERICH4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:81,123,556...81,125,296
Ensembl chr 1:81,123,556...81,125,296
|
|
G |
Ermap |
erythroblast membrane associated protein (Scianna blood group) |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ERMAP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:132,788,847...132,803,030
Ensembl chr 5:132,789,991...132,802,847
|
|
G |
Erp27 |
endoplasmic reticulum protein 27 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ERP27 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:169,804,656...169,821,660
Ensembl chr 4:169,804,658...169,821,660
|
|
G |
Esam |
endothelial cell adhesion molecule |
increases expression |
ISO |
propionaldehyde results in increased expression of ESAM mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:37,238,228...37,249,217
Ensembl chr 8:37,238,287...37,249,215
|
|
G |
Esco2 |
establishment of sister chromatid cohesion N-acetyltransferase 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ESCO2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:40,034,566...40,052,295
Ensembl chr15:40,034,568...40,055,306
|
|
G |
Espl1 |
extra spindle pole bodies like 1, separase |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ESPL1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:133,424,027...133,450,984
Ensembl chr 7:133,424,130...133,450,984
|
|
G |
Etnk2 |
ethanolamine kinase 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of ETNK2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:44,811,012...44,829,052
Ensembl chr13:44,811,015...44,829,037
|
|
G |
Ets2 |
ETS proto-oncogene 2, transcription factor |
decreases expression |
ISO |
propionaldehyde results in decreased expression of ETS2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:35,021,536...35,038,322
Ensembl chr11:35,021,596...35,038,319
|
|
G |
Evi5l |
ecotropic viral integration site 5-like |
increases expression |
ISO |
propionaldehyde results in increased expression of EVI5L mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:2,519,648...2,558,766
Ensembl chr12:2,519,671...2,559,950
|
|
G |
Exoc3l4 |
exocyst complex component 3-like 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of EXOC3L4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:130,452,680...130,466,684
Ensembl chr 6:130,452,661...130,466,683
|
|
G |
Exosc8 |
exosome component 8 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of EXOSC8 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:138,930,405...138,937,009
Ensembl chr 2:138,930,405...138,936,928
|
|
G |
Exph5 |
exophilin 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of EXPH5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:53,698,825...53,775,371
Ensembl chr 8:53,698,852...53,773,169
|
|
G |
F13b |
coagulation factor XIII B chain |
decreases expression |
ISO |
propionaldehyde results in decreased expression of F13B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:51,130,908...51,156,383
Ensembl chr13:51,130,920...51,156,381
|
|
G |
F2 |
coagulation factor II, thrombin |
decreases expression |
ISO |
propionaldehyde results in decreased expression of F2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
|
|
G |
F2r |
coagulation factor II (thrombin) receptor |
increases expression |
ISO |
propionaldehyde results in increased expression of F2R mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:26,869,343...26,885,856
Ensembl chr 2:26,868,404...26,885,870
|
|
G |
F5 |
coagulation factor V |
decreases expression |
ISO |
propionaldehyde results in decreased expression of F5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:76,513,509...76,583,106
Ensembl chr13:76,513,255...76,582,317
|
|
G |
F7 |
coagulation factor VII |
decreases expression |
ISO |
propionaldehyde results in decreased expression of F7 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:76,489,775...76,500,636
Ensembl chr16:76,489,717...76,500,610
|
|
G |
Fa2h |
fatty acid 2-hydroxylase |
increases expression |
ISO |
propionaldehyde results in increased expression of FA2H mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:39,312,904...39,364,153
Ensembl chr19:39,312,906...39,364,153
|
|
G |
Faap24 |
FA core complex associated protein 24 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FAAP24 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:88,051,523...88,057,997
Ensembl chr 1:88,051,911...88,057,989
|
|
G |
Fabp6 |
fatty acid binding protein 6 |
increases expression |
ISO |
propionaldehyde results in increased expression of FABP6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:28,063,603...28,068,276
Ensembl chr10:28,063,603...28,068,282
|
|
G |
Fam110a |
family with sequence similarity 110, member A |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FAM110A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:140,474,484...140,485,074
Ensembl chr 3:140,474,249...140,485,093
|
|
G |
Fam13a |
family with sequence similarity 13, member A |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FAM13A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:88,056,521...88,155,782
Ensembl chr 4:88,058,403...88,155,860
|
|
G |
Fam184a |
family with sequence similarity 184, member A |
increases expression |
ISO |
propionaldehyde results in increased expression of FAM184A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr20:32,934,424...33,056,626
Ensembl chr20:32,934,636...33,056,652
|
|
G |
Fam25a |
family with sequence similarity 25, member A |
increases expression |
ISO |
propionaldehyde results in increased expression of FAM25A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:9,680,668...9,684,474
Ensembl chr16:9,680,668...9,684,474
|
|
G |
Fam43a |
family with sequence similarity 43, member A |
increases expression |
ISO |
propionaldehyde results in increased expression of FAM43A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:70,128,253...70,131,401
Ensembl chr11:70,128,253...70,131,401
|
|
G |
Fam43b |
family with sequence similarity 43, member B |
increases expression |
ISO |
propionaldehyde results in increased expression of FAM43B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:150,610,656...150,613,054
Ensembl chr 5:150,611,609...150,612,601
|
|
G |
Fam90a1a |
family with sequence similarity 90 member A1A |
increases expression |
ISO |
propionaldehyde results in increased expression of FAM90A1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:70,098,439...70,106,147
Ensembl chr16:70,098,740...70,101,241
|
|
G |
Fancd2 |
FA complementation group D2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FANCD2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:146,679,014...146,743,422
Ensembl chr 4:146,679,179...146,743,412
|
|
G |
Fanci |
FA complementation group I |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FANCI mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:133,327,264...133,383,661
Ensembl chr 1:133,327,297...133,383,640
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
ISO |
propionaldehyde results in increased expression of FAS mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Faslg |
Fas ligand |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FASLG mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fblim1 |
filamin binding LIM protein 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of FBLIM1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:153,883,945...153,915,524
Ensembl chr 5:153,883,960...153,913,757
|
|
G |
Fbln2 |
fibulin 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of FBLN2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:123,704,289...123,763,857
Ensembl chr 4:123,704,373...123,763,948
|
|
G |
Fbln5 |
fibulin 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of FBLN5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:120,899,219...120,977,829
Ensembl chr 6:120,899,224...120,977,755
|
|
G |
Fbn2 |
fibrillin 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of FBN2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:51,499,670...51,703,976
Ensembl chr18:51,499,737...51,703,976
|
|
G |
Fbxo2 |
F-box protein 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of FBXO2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:158,592,926...158,598,355
Ensembl chr 5:158,592,925...158,598,355
|
|
G |
Fbxo24 |
F-box protein 24 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FBXO24 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:19,072,668...19,083,067
Ensembl chr12:19,072,716...19,083,067
|
|
G |
Fbxo41 |
F-box protein 41 |
increases expression |
ISO |
propionaldehyde results in increased expression of FBXO41 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:118,007,517...118,039,547
Ensembl chr 4:118,010,978...118,039,406
|
|
G |
Fbxo43 |
F-box protein 43 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FBXO43 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:67,333,161...67,346,751
Ensembl chr 7:67,333,162...67,346,751
|
|
G |
Fbxo5 |
F-box protein 5 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FBXO5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:42,196,068...42,202,437
Ensembl chr 1:42,196,068...42,202,437
|
|
G |
Fbxw12 |
F-box and WD repeat domain containing 12 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FBXW12 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:109,782,315...109,802,086
Ensembl chr 8:109,786,815...109,801,813
|
|
G |
Fcrl2 |
Fc receptor-like 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FCRL2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:172,694,308...172,707,261
Ensembl chr 2:172,694,308...172,707,051
|
|
G |
Fdxr |
ferredoxin reductase |
increases expression |
ISO |
propionaldehyde results in increased expression of FDXR mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:100,507,863...100,516,649
Ensembl chr10:100,507,865...100,516,658
|
|
G |
Fer1l6 |
fer-1-like family member 6 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FER1L6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:90,093,567...90,216,907
Ensembl chr 7:90,061,924...90,215,214
|
|
G |
Fez1 |
fasciculation and elongation protein zeta 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of FEZ1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:36,544,462...36,589,684
Ensembl chr 8:36,544,535...36,589,683
|
|
G |
Ffar2 |
free fatty acid receptor 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FFAR2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:86,071,855...86,075,049
Ensembl chr 1:86,072,184...86,075,033
|
|
G |
Fga |
fibrinogen alpha chain |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FGA mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:168,374,120...168,381,523
Ensembl chr 2:168,374,120...168,381,528
|
|
G |
Fgb |
fibrinogen beta chain |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FGB mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:168,394,901...168,402,863
Ensembl chr 2:168,394,916...168,405,979
|
|
G |
Fgd3 |
FYVE, RhoGEF and PH domain containing 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of FGD3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:15,324,848...15,387,271
Ensembl chr17:15,336,837...15,385,712
|
|
G |
Fgf13 |
fibroblast growth factor 13 |
increases expression |
ISO |
propionaldehyde results in increased expression of FGF13 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:137,276,498...137,800,056
Ensembl chr X:137,276,511...137,800,391
|
|
G |
Fgf20 |
fibroblast growth factor 20 |
increases expression |
ISO |
propionaldehyde results in increased expression of FGF20 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:52,030,549...52,038,201
Ensembl chr16:52,010,194...52,038,204
|
|
G |
Fgfbp1 |
fibroblast growth factor binding protein 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of FGFBP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:67,103,686...67,107,492
Ensembl chr14:67,104,545...67,107,496
|
|
G |
Fgfbp3 |
fibroblast growth factor binding protein 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of FGFBP3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:234,644,023...234,646,028
Ensembl chr 1:234,644,019...234,646,547
|
|
G |
Fgg |
fibrinogen gamma chain |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FGG mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:168,354,880...168,362,325
Ensembl chr 2:168,355,013...168,362,322
|
|
G |
Fgl1 |
fibrinogen-like 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FGL1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:51,120,652...51,150,907
Ensembl chr16:51,120,694...51,151,093
|
|
G |
Fhl2 |
four and a half LIM domains 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of FHL2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:45,388,979...45,462,421
Ensembl chr 9:45,388,981...45,431,192
|
|
G |
Fhod3 |
formin homology 2 domain containing 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of FHOD3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:15,993,079...16,425,796
Ensembl chr18:15,993,324...16,425,796
|
|
G |
Fignl1 |
fidgetin-like 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FIGNL1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:86,368,670...86,381,728
Ensembl chr14:86,368,675...86,377,455
|
|
G |
Fkbp1b |
FKBP prolyl isomerase 1B |
increases expression |
ISO |
propionaldehyde results in increased expression of FKBP1B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:27,832,128...27,850,600
Ensembl chr 6:27,838,802...27,848,653
|
|
G |
Flcn |
folliculin |
increases expression |
ISO |
propionaldehyde results in increased expression of FLCN mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:44,588,621...44,607,808
Ensembl chr10:44,588,624...44,607,769
|
|
G |
Flna |
filamin A |
increases expression |
ISO |
propionaldehyde results in increased expression of FLNA mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:152,007,758...152,034,266
Ensembl chr X:152,007,758...152,031,052
|
|
G |
Flywch1 |
FLYWCH-type zinc finger 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of FLYWCH1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:12,774,644...12,794,373
Ensembl chr10:12,774,653...12,794,267
|
|
G |
Fmo4 |
flavin containing dimethylaniline monoxygenase 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of FMO4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:75,154,683...75,172,874
Ensembl chr13:75,154,684...75,172,874
|
|
G |
Fmo5 |
flavin containing dimethylaniline monoxygenase 5 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FMO5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:185,197,184...185,249,699
Ensembl chr 2:185,222,204...185,249,693
|
|
G |
Fmod |
fibromodulin |
increases expression |
ISO |
propionaldehyde results in increased expression of FMOD mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:45,493,517...45,504,134
Ensembl chr13:45,493,517...45,504,133
|
|
G |
Fn3k |
fructosamine 3 kinase |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FN3K mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:106,700,670...106,715,903
Ensembl chr10:106,700,670...106,715,895
|
|
G |
Fndc11 |
fibronectin type III domain containing 11 |
increases expression |
ISO |
propionaldehyde results in increased expression of FNDC11 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:168,330,607...168,333,111
Ensembl chr 3:168,330,602...168,334,617
|
|
G |
Fndc3b |
fibronectin type III domain containing 3B |
increases expression |
ISO |
propionaldehyde results in increased expression of FNDC3B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:110,311,439...110,617,504
Ensembl chr 2:110,312,694...110,547,830
|
|
G |
Fndc5 |
fibronectin type III domain containing 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of FNDC5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:141,481,593...141,491,257
Ensembl chr 5:141,481,590...141,490,731
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FOS mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Foxm1 |
forkhead box M1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FOXM1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:161,639,538...161,652,012
Ensembl chr 4:161,638,816...161,650,684
|
|
G |
Foxn4 |
forkhead box N4 |
increases expression |
ISO |
propionaldehyde results in increased expression of FOXN4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:42,336,706...42,359,932
Ensembl chr12:42,340,323...42,359,921
|
|
G |
Fpr1 |
formyl peptide receptor 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of FPR1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:58,745,019...58,756,776
Ensembl chr 1:58,747,246...58,756,559
|
|
G |
Frat1 |
FRAT regulator of WNT signaling pathway 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FRAT1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:240,638,309...240,640,857
Ensembl chr 1:240,638,296...240,640,945
|
|
G |
Frg2 |
FSHD region gene 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of FRG2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:80,427,260...80,429,560
Ensembl chr14:80,427,673...80,429,181
|
|
G |
Frmd4b |
FERM domain containing 4B |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FRMD4B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:129,895,401...130,222,070
Ensembl chr 4:129,895,708...130,084,197
|
|
G |
Frmd5 |
FERM domain containing 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of FRMD5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:108,492,099...108,763,715
Ensembl chr 3:108,474,562...108,763,498
|
|
G |
Frmd8 |
FERM domain containing 8 |
increases expression |
ISO |
propionaldehyde results in increased expression of FRMD8 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:203,143,216...203,163,868
Ensembl chr 1:203,143,218...203,163,870
|
|
G |
Frrs1 |
ferric-chelate reductase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of FRRS1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:204,820,898...204,881,487
Ensembl chr 2:204,823,025...204,895,540
|
|
G |
Fry |
FRY microtubule binding protein |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FRY mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:4,493,890...4,887,118
Ensembl chr12:4,493,891...4,799,116
|
|
G |
Frzb |
frizzled-related protein |
increases expression |
ISO |
propionaldehyde results in increased expression of FRZB mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:65,332,274...65,365,208
Ensembl chr 3:65,332,277...65,365,208
|
|
G |
Fscn1 |
fascin actin-bundling protein 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of FSCN1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:11,597,042...11,610,183
Ensembl chr12:11,597,048...11,610,211
|
|
G |
Fstl3 |
follistatin like 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of FSTL3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:9,923,574...9,929,223
Ensembl chr 7:9,923,576...9,939,639
|
|
G |
Fstl4 |
follistatin-like 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of FSTL4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:36,911,422...37,344,545
Ensembl chr10:36,911,420...37,338,588
|
|
G |
Ftcd |
formimidoyltransferase cyclodeaminase |
increases expression |
ISO |
propionaldehyde results in increased expression of FTCD mRNA |
CTD |
PMID:26079696 |
|
NCBI chr20:12,055,203...12,068,717
Ensembl chr20:12,055,208...12,068,735
|
|
G |
Fuom |
fucose mutarotase |
increases expression |
ISO |
propionaldehyde results in increased expression of FUOM mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:194,888,535...194,893,046
Ensembl chr 1:194,886,709...194,893,046
|
|
G |
Fxyd2 |
FXYD domain-containing ion transport regulator 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of FXYD2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:45,712,901...45,720,032
Ensembl chr 8:45,712,903...45,720,203
|
|
G |
Fxyd7 |
FXYD domain-containing ion transport regulator 7 |
increases expression |
ISO |
propionaldehyde results in increased expression of FXYD7 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:86,277,678...86,286,954
Ensembl chr 1:86,277,678...86,286,954
|
|
G |
Fyn |
FYN proto-oncogene, Src family tyrosine kinase |
increases expression |
ISO |
propionaldehyde results in increased expression of FYN mRNA |
CTD |
PMID:26079696 |
|
NCBI chr20:42,767,733...42,960,903
Ensembl chr20:42,766,369...42,959,911
|
|
G |
Gabbr2 |
gamma-aminobutyric acid type B receptor subunit 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of GABBR2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:60,947,517...61,288,104
Ensembl chr 5:60,947,526...61,288,104
|
|
G |
Gad1 |
glutamate decarboxylase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of GAD1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:55,369,704...55,410,335
Ensembl chr 3:55,369,704...55,410,333
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
increases expression |
ISO |
propionaldehyde results in increased expression of GADD45A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Gadd45g |
growth arrest and DNA-damage-inducible, gamma |
increases expression |
ISO |
propionaldehyde results in increased expression of GADD45G mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:13,376,842...13,378,587
Ensembl chr17:13,376,839...13,378,610
|
|
G |
Gal |
galanin and GMAP prepropeptide |
increases expression |
ISO |
propionaldehyde results in increased expression of GAL mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:200,650,439...200,655,302
Ensembl chr 1:200,650,439...200,654,959
|
|
G |
Gal3st1 |
galactose-3-O-sulfotransferase 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GAL3ST1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:78,868,049...78,886,402
Ensembl chr14:78,870,793...78,886,388
|
|
G |
Galnt10 |
polypeptide N-acetylgalactosaminyltransferase 10 |
increases expression |
ISO |
propionaldehyde results in increased expression of GALNT10 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:41,821,216...41,967,618
Ensembl chr10:41,820,158...41,967,013
|
|
G |
Galnt16 |
polypeptide N-acetylgalactosaminyltransferase 16 |
increases expression |
ISO |
propionaldehyde results in increased expression of GALNT16 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:100,168,943...100,250,718
Ensembl chr 6:100,170,306...100,250,705
|
|
G |
Galnt18 |
polypeptide N-acetylgalactosaminyltransferase 18 |
increases expression |
ISO |
propionaldehyde results in increased expression of GALNT18 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:165,593,180...165,904,268
Ensembl chr 1:165,593,187...165,904,268
|
|
G |
Galnt5 |
polypeptide N-acetylgalactosaminyltransferase 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of GALNT5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:42,573,622...42,619,881
Ensembl chr 3:42,573,622...42,619,881
|
|
G |
Galnt6 |
polypeptide N-acetylgalactosaminyltransferase 6 |
increases expression |
ISO |
propionaldehyde results in increased expression of GALNT6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:131,789,836...131,828,077
Ensembl chr 7:131,789,839...131,819,661
|
|
G |
Galntl6 |
polypeptide N-acetylgalactosaminyltransferase-like 6 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GALNTL6 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:31,192,880...32,443,979
Ensembl chr16:31,186,462...32,441,960
|
|
G |
Gamt |
guanidinoacetate N-methyltransferase |
increases expression |
ISO |
propionaldehyde results in increased expression of GAMT mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:9,448,590...9,451,413
Ensembl chr 7:9,448,628...9,451,778
|
|
G |
Garin1b |
golgi associated RAB2 interactor 1B |
increases expression |
ISO |
propionaldehyde results in increased expression of GARIN1B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:57,915,184...57,938,593
Ensembl chr 4:57,920,790...57,938,591
|
|
G |
Garnl3 |
GTPase activating Rap/RanGAP domain-like 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of GARNL3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:16,288,718...16,432,308
Ensembl chr 3:16,288,719...16,430,837
|
|
G |
Gas2l3 |
growth arrest-specific 2 like 3 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GAS2L3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:23,803,578...23,836,816
Ensembl chr 7:23,806,310...23,836,411
|
|
G |
Gata5 |
GATA binding protein 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of GATA5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:167,418,563...167,426,751
Ensembl chr 3:167,418,565...167,426,751
|
|
G |
Gba3 |
glucosylceramidase beta 3 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GBA3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:60,574,974...60,721,411
Ensembl chr14:60,574,976...60,721,653
|
|
G |
Gbp1 |
guanylate binding protein 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of GBP1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:231,398,136...231,432,773
Ensembl chr 2:231,398,163...231,432,131 Ensembl chr 2:231,398,163...231,432,131
|
|
G |
Gbx2 |
gastrulation brain homeobox 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of GBX2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 9:90,509,633...90,512,212
Ensembl chr 9:90,509,633...90,512,212
|
|
G |
Gcgr |
glucagon receptor |
increases expression |
ISO |
propionaldehyde results in increased expression of GCGR mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:105,808,474...105,816,641
Ensembl chr10:105,808,473...105,816,640
|
|
G |
Gckr |
glucokinase regulator |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GCKR mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:25,044,592...25,075,834
Ensembl chr 6:25,045,100...25,075,654
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GCLC mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of GCNT1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:214,718,344...214,755,735
Ensembl chr 1:214,718,293...214,758,776
|
|
G |
Gdf11 |
growth differentiation factor 11 |
increases expression |
ISO |
propionaldehyde results in increased expression of GDF11 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:1,311,732...1,325,211
Ensembl chr 7:1,311,732...1,320,725
|
|
G |
Gdf15 |
growth differentiation factor 15 |
increases expression |
ISO |
propionaldehyde results in increased expression of GDF15 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
|
|
G |
Gdpd1 |
glycerophosphodiester phosphodiesterase domain containing 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of GDPD1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:71,840,497...71,883,936
Ensembl chr10:71,840,497...71,883,850
|
|
G |
Gfi1 |
growth factor independent 1 transcriptional repressor |
increases expression |
ISO |
propionaldehyde results in increased expression of GFI1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr14:2,040,576...2,056,874
Ensembl chr14:2,042,434...2,051,814
|
|
G |
Gfod1 |
Gfo/Idh/MocA-like oxidoreductase domain containing 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of GFOD1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:21,400,142...21,504,972
Ensembl chr17:21,399,479...21,499,938
|
|
G |
Gfra1 |
GDNF family receptor alpha 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of GFRA1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:257,315,682...257,552,004
Ensembl chr 1:257,321,742...257,551,473
|
|
G |
Gfra4 |
GDNF family receptor alpha 4 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GFRA4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:118,254,937...118,262,252
Ensembl chr 3:118,255,402...118,258,329
|
|
G |
Gins1 |
GINS complex subunit 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GINS1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:139,724,513...139,745,930
Ensembl chr 3:139,724,490...139,745,936
|
|
G |
Gins2 |
GINS complex subunit 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GINS2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:48,626,770...48,639,523
Ensembl chr19:48,626,770...48,639,339
|
|
G |
Gja3 |
gap junction protein, alpha 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of GJA3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:31,181,360...31,206,820
Ensembl chr15:31,181,369...31,206,810
|
|
G |
Gjb1 |
gap junction protein, beta 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GJB1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:66,501,848...66,509,783
Ensembl chr X:66,501,820...66,509,925
|
|
G |
Gjb2 |
gap junction protein, beta 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of GJB2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr15:31,260,390...31,278,222
Ensembl chr15:31,260,357...31,278,177
|
|
G |
Gjb4 |
gap junction protein, beta 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of GJB4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:139,675,776...139,679,551
Ensembl chr 5:139,675,780...139,679,667
|
|
G |
Gjb5 |
gap junction protein, beta 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of GJB5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:139,680,670...139,683,588
Ensembl chr 5:139,680,671...139,683,583
|
|
G |
Gjd3 |
gap junction protein, delta 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of GJD3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:83,933,694...83,935,759
Ensembl chr10:83,934,135...83,934,971
|
|
G |
Gkn1 |
gastrokine 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of GKN1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:119,790,101...119,795,389
Ensembl chr 4:119,790,101...119,795,389
|
|
G |
Gkn2 |
gastrokine 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of GKN2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:119,778,326...119,824,366
Ensembl chr 4:119,818,280...119,824,363
|
|
G |
Gldc |
glycine decarboxylase |
increases expression |
ISO |
propionaldehyde results in increased expression of GLDC mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:227,883,249...227,962,119
Ensembl chr 1:227,883,249...227,962,097
|
|
G |
Glipr1 |
GLI pathogenesis-related 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of GLIPR1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:47,487,342...47,498,974
Ensembl chr 7:47,487,345...47,498,429
|
|
G |
Glipr2 |
GLI pathogenesis-related 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of GLIPR2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:58,170,417...58,202,258
Ensembl chr 5:58,170,425...58,202,272
|
|
G |
Glyctk |
glycerate kinase |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GLYCTK mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:106,795,461...106,802,675
Ensembl chr 8:106,797,343...106,802,397
|
|
G |
Gm2a |
ganglioside GM2 activator |
increases expression |
ISO |
propionaldehyde results in increased expression of GM2A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:39,219,221...39,231,756
Ensembl chr10:39,219,243...39,231,757
|
|
G |
Gmpr |
guanosine monophosphate reductase |
increases expression |
ISO |
propionaldehyde results in increased expression of GMPR mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:19,151,820...19,189,626
Ensembl chr17:19,151,815...19,189,621
|
|
G |
Gnao1 |
G protein subunit alpha o1 |
increases expression |
ISO |
propionaldehyde results in increased expression of GNAO1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:11,034,874...11,192,531
Ensembl chr19:11,035,956...11,192,493
|
|
G |
Gnaz |
G protein subunit alpha z |
increases expression |
ISO |
propionaldehyde results in increased expression of GNAZ mRNA |
CTD |
PMID:26079696 |
|
NCBI chr20:13,643,473...13,694,240
Ensembl chr20:13,644,640...13,669,907
|
|
G |
Gng7 |
G protein subunit gamma 7 |
increases expression |
ISO |
propionaldehyde results in increased expression of GNG7 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:8,697,458...8,761,239
Ensembl chr 7:8,697,521...8,761,240
|
|
G |
Golga7b |
golgin A7 family, member B |
increases expression |
ISO |
propionaldehyde results in increased expression of GOLGA7B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:241,056,427...241,080,890
Ensembl chr 1:241,059,171...241,079,081
|
|
G |
Gpr143 |
G protein-coupled receptor 143 |
increases expression |
ISO |
propionaldehyde results in increased expression of GPR143 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:22,002,914...22,027,720
Ensembl chr X:22,002,914...22,027,715
|
|
G |
Gpr146 |
G protein-coupled receptor 146 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GPR146 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:15,251,936...15,267,217
Ensembl chr12:15,251,813...15,267,206
|
|
G |
Gpr155 |
G protein-coupled receptor 155 |
increases expression |
ISO |
propionaldehyde results in increased expression of GPR155 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:58,216,422...58,270,350
Ensembl chr 3:58,216,423...58,270,275
|
|
G |
Gpr160 |
G protein-coupled receptor 160 |
increases expression |
ISO |
propionaldehyde results in increased expression of GPR160 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:112,483,364...112,563,072
Ensembl chr 2:112,484,935...112,563,148
|
|
G |
Gpr173 |
G-protein coupled receptor 173 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GPR173 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr X:21,446,261...21,471,119
Ensembl chr X:21,447,361...21,471,498
|
|
G |
Gpr20 |
G protein-coupled receptor 20 |
increases expression |
ISO |
propionaldehyde results in increased expression of GPR20 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:105,601,761...105,611,959
Ensembl chr 7:105,602,368...105,603,430
|
|
G |
Gpr37l1 |
G protein-coupled receptor 37-like 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of GPR37L1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr13:46,598,574...46,605,421
Ensembl chr13:46,598,578...46,605,421
|
|
G |
Gpr87 |
G protein-coupled receptor 87 |
increases expression |
ISO |
propionaldehyde results in increased expression of GPR87 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:143,439,741...143,440,901
Ensembl chr 2:143,439,735...143,458,190
|
|
G |
Gprc5a |
G protein-coupled receptor, class C, group 5, member A |
increases expression |
ISO |
propionaldehyde results in increased expression of GPRC5A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:167,903,542...167,922,276
Ensembl chr 4:167,903,542...167,922,260
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of GPX1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GPX2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
|
|
G |
Gramd1c |
GRAM domain containing 1C |
increases expression |
ISO |
propionaldehyde results in increased expression of GRAMD1C mRNA |
CTD |
PMID:26079696 |
|
NCBI chr11:56,633,229...56,718,570
Ensembl chr11:56,633,227...56,718,570
|
|
G |
Gramd2b |
GRAM domain containing 2B |
increases expression |
ISO |
propionaldehyde results in increased expression of GRAMD2B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:49,884,014...49,981,955
Ensembl chr18:49,884,014...49,981,953
|
|
G |
Greb1l |
GREB1 like retinoic acid receptor coactivator |
increases expression |
ISO |
propionaldehyde results in increased expression of GREB1L mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:1,392,330...1,629,483
Ensembl chr18:1,392,725...1,628,067
|
|
G |
Grhl1 |
grainyhead-like transcription factor 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of GRHL1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 6:41,207,325...41,257,516
Ensembl chr 6:41,207,348...41,254,301
|
|
G |
Grhl3 |
grainyhead-like transcription factor 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of GRHL3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:147,774,161...147,806,291
Ensembl chr 5:147,774,160...147,806,160
|
|
G |
Grin2c |
glutamate ionotropic receptor NMDA type subunit 2C |
increases expression |
ISO |
propionaldehyde results in increased expression of GRIN2C mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:100,488,430...100,507,083
Ensembl chr10:100,488,431...100,506,427
|
|
G |
Grin3b |
glutamate ionotropic receptor NMDA type subunit 3B |
increases expression |
ISO |
propionaldehyde results in increased expression of GRIN3B mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:9,730,861...9,737,183
Ensembl chr 7:9,730,862...9,737,183
|
|
G |
Grm4 |
glutamate metabotropic receptor 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of GRM4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr20:5,484,172...5,572,821
Ensembl chr20:5,481,124...5,572,821
|
|
G |
Grp |
gastrin releasing peptide |
increases expression |
ISO |
propionaldehyde results in increased expression of GRP mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:59,388,679...59,402,061
Ensembl chr18:59,388,274...59,402,061
|
|
G |
Gsta5 |
glutathione S-transferase alpha 5 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GSTA5 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:79,105,561...79,117,472
Ensembl chr 8:79,105,661...79,117,472
|
|
G |
Gstm5 |
glutathione S-transferase, mu 5 |
increases expression |
ISO |
propionaldehyde results in increased expression of GSTM3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:195,531,599...195,534,562
Ensembl chr 2:195,531,495...195,534,553
|
|
G |
Gsto2 |
glutathione S-transferase omega 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of GSTO2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:246,731,314...246,757,592
Ensembl chr 1:246,732,089...246,753,866
|
|
G |
Gtf2ird2 |
GTF2I repeat domain containing 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GTF2IRD2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr12:22,497,767...22,536,455
Ensembl chr12:22,498,091...22,536,263
|
|
G |
Gtse1 |
G-2 and S-phase expressed 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GTSE1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:116,949,997...116,966,826
Ensembl chr 7:116,950,053...116,966,806
|
|
G |
Guca2a |
guanylate cyclase activator 2A |
decreases expression |
ISO |
propionaldehyde results in decreased expression of GUCA2A mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:133,237,177...133,239,019
Ensembl chr 5:133,237,177...133,239,018
|
|
G |
Gucy1b1 |
guanylate cyclase 1 soluble subunit beta 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of GUCY1B1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:167,348,824...167,398,983
Ensembl chr 2:167,348,825...167,398,916
|
|
G |
H19 |
H19 imprinted maternally expressed transcript |
decreases expression |
ISO |
propionaldehyde results in decreased expression of H19 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:197,730,698...197,733,374
Ensembl chr 1:197,730,698...197,733,134
|
|
G |
H1f4 |
H1.4 linker histone, cluster member |
decreases expression |
ISO |
propionaldehyde results in decreased expression of H1-4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:41,486,574...41,487,355
Ensembl chr17:41,486,560...41,487,403
|
|
G |
H1f8 |
H1.8 linker histone |
decreases expression |
ISO |
propionaldehyde results in decreased expression of H1-8 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 4:148,993,133...148,998,254
Ensembl chr 4:148,993,133...148,998,254
|
|
G |
H2ac1 |
H2A clustered histone 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of H2AC1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:41,171,324...41,171,801
Ensembl chr17:41,135,489...41,172,022
|
|
G |
H2ac20 |
H2A clustered histone 20 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of H2AC20 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:183,779,879...183,780,357
|
|
G |
H2ac21 |
H2A clustered histone 21 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of H2AC21 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:183,779,355...183,779,788
|
|
G |
H2ac25 |
H2A clustered histone 25 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of H2AC25 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:43,733,702...43,735,254
Ensembl chr10:43,733,668...43,744,874
|
|
G |
H2ac4 |
H2A clustered histone 4 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of H2AC4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:42,799,884...42,800,387
Ensembl chr17:42,799,652...42,800,381
|
|
G |
H2bc6 |
H2B clustered histone 6 |
increases methylation decreases expression |
ISO |
propionaldehyde results in increased methylation of H2BC6 gene propionaldehyde results in decreased expression of H2BC6 mRNA |
CTD |
PMID:26079696 PMID:30002397 |
|
NCBI chr17:41,520,775...41,521,238
|
|
G |
H4c14 |
H4 clustered histone 14 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of H4C2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:183,831,601...183,831,996
Ensembl chr 2:183,825,994...183,832,048
|
|
G |
Habp2 |
hyaluronan binding protein 2 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of HABP2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:255,315,870...255,350,161
Ensembl chr 1:255,315,915...255,350,160
|
|
G |
Hao1 |
hydroxyacid oxidase 1 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of HAO1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 3:121,757,400...121,828,721
Ensembl chr 3:121,771,836...121,828,721
|
|
G |
Hapln3 |
hyaluronan and proteoglycan link protein 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of HAPLN3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:133,046,465...133,064,665
Ensembl chr 1:133,046,467...133,080,177
|
|
G |
Hapln4 |
hyaluronan and proteoglycan link protein 4 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of HAPLN4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr16:19,333,106...19,341,243
Ensembl chr16:19,333,106...19,341,243
|
|
G |
Has3 |
hyaluronan synthase 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of HAS3 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr19:34,768,421...34,782,170
Ensembl chr19:34,771,982...34,782,592
|
|
G |
Haspin |
histone H3 associated protein kinase |
decreases expression |
ISO |
propionaldehyde results in decreased expression of HASPIN mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:57,747,731...57,750,518
Ensembl chr10:57,747,573...57,750,512
|
|
G |
Hba-a3 |
hemoglobin alpha, adult chain 3 |
increases expression |
ISO |
propionaldehyde results in increased expression of HBA2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:15,311,637...15,312,481
Ensembl chr10:15,311,634...15,312,481
|
|
G |
Hbe1 |
hemoglobin subunit epsilon 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of HBE1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:158,282,931...158,458,855
Ensembl chr 1:158,282,936...158,284,391
|
|
G |
Hbegf |
heparin-binding EGF-like growth factor |
increases expression |
ISO |
propionaldehyde results in increased expression of HBEGF mRNA |
CTD |
PMID:26079696 |
|
NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
|
|
G |
Hbg1 |
hemoglobin subunit gamma 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of HBG1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:158,271,871...158,273,426
Ensembl chr 1:158,271,873...158,273,425
|
|
G |
Hbq1b |
hemoglobin subunit theta 1B |
increases expression |
ISO |
propionaldehyde results in increased expression of HBQ1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:15,334,293...15,336,061
Ensembl chr10:15,320,762...15,321,397 Ensembl chr10:15,320,762...15,321,397
|
|
G |
Hcn4 |
hyperpolarization activated cyclic nucleotide-gated potassium channel 4 |
increases expression |
ISO |
propionaldehyde results in increased expression of HCN4 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 8:59,222,206...59,259,626
Ensembl chr 8:59,221,653...59,259,639
|
|
G |
Hcst |
hematopoietic cell signal transducer |
increases expression |
ISO |
propionaldehyde results in increased expression of HCST mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 1:85,676,976...85,679,083
Ensembl chr 1:85,676,979...85,679,012
|
|
G |
Hdac7 |
histone deacetylase 7 |
decreases expression |
ISO |
propionaldehyde results in decreased expression of HDAC7 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 7:128,923,918...128,961,926
Ensembl chr 7:128,923,920...128,962,072
|
|
G |
Hes2 |
hes family bHLH transcription factor 2 |
increases expression |
ISO |
propionaldehyde results in increased expression of HES2 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 5:162,667,190...162,668,235
Ensembl chr 5:162,667,190...162,668,235
|
|
G |
Hes7 |
hes family bHLH transcription factor 7 |
increases expression |
ISO |
propionaldehyde results in increased expression of HES7 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr10:53,824,124...53,828,934
Ensembl chr10:53,825,574...53,828,097
|
|
G |
Hey1 |
hes-related family bHLH transcription factor with YRPW motif 1 |
increases expression |
ISO |
propionaldehyde results in increased expression of HEY1 mRNA |
CTD |
PMID:26079696 |
|
NCBI chr 2:93,096,605...93,100,316
Ensembl chr 2:93,095,498...93,100,312
|
|
G |
Hfe |
homeostatic iron regulator |
decreases expression |
ISO |
propionaldehyde results in decreased expression of HFE mRNA |
CTD |
PMID:26079696 |
|
NCBI chr17:41,413,451...41,421,502
Ensembl chr17:41,413,451...41,421,502
|
| |